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1. ABSTRACT 
 
Involvement of CypP4504a in Adenosine A1 receptor mediated regulation of 
vascular tone 
 
Swati S Kunduri 
 
Cardiovascular diseases are one of the leading causes of morbidity and mortality 
worldwide. The regulation of vascular tone plays an important role in normal 
cardiovascular function. Adenosine, an autacoid has several physiological and 
pathophysiological roles, apart from the regulation of vascular tone. Adenosine receptor 
(AR) contracts and relaxes blood vessels through all four subtypes (A1, A2A, A2B, and A3) 
linked to different signaling mechanisms. Deciphering complex tissue responses remains 
difficult because relationships of individual receptor subtypes and various end-effectors 
(e.g., ion channels) are yet to be identified. Apart from adenosine, 20-HETE, a 
cytochrome P4504a (Cyp4a) metabolite of arachidonic acid (AA) is a potent 
vasoconstrictor.  
 
We hypothesized that A1AR induced contraction of the smooth muscle involves Cyp4a, 
with Protein Kinase C (PKC)-α, extracellular regulated kinase (ERK) 1/2 contributing to 
the downstream signaling events. Another key question we addressed were the ion 
channel(s) contributing to smooth muscle contraction. Experiments included isometric 
tension recordings of aortic contraction and western blots. In addition, patch clamp 
experiments were done with freshly isolated smooth muscle cells from wild type (WT) 
and A1 knockout (A1KO) mice aortae. We found that inhibition of Cyp4a led to lesser 
contraction in the adenosine agonists’ mediated responses. 20-HETE induced contraction 
in both WT and A1KO, but this response was lower in A1KO.  Inhibition of PKC-α and 
ERK1/2 attenuated the 20-HETE-induced contraction in both WT and A1KO. These 
findings suggest that A1AR couples with 20-HETE and negatively modulates vascular 
tone through PKC- α and ERK1/2. Furthermore, electrophysiological experiments 
revealed that non-selective adenosine agonist increased the BK current in A1KO as 
compared to the WT. This suggests A1 receptors have a negative regulatory effect on BK 
current. On the other hand, A1 selective agonist decreased the BK current in WT, with no 
effect on A1KO.  PKC-α inhibitor abolished the effect of the A1 selective agonist on BK 
current. These findings suggest that A1AR regulates contraction of the aortic smooth 
muscle through inhibition of BK channels in a PKC-α dependent manner. From these 
data, we conclude that A1AR negatively couples with 20-HETE and by inhibiting BK 
channels mediates smooth muscle contraction via PKC- α. 
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1. CHAPTER ONE: INTRODUCTION 
 
Adenosine, the breakdown product of the energy molecule adenosine triphosphate 
(ATP), is a ubiquitous nucleoside. In mammalian cells it plays a key role in a number of 
physiological and pathophysiological conditions. Figure 1.1 shows the chemical structure 
of Adenosine.  Under physiological conditions, some of its regulatory activities include 
decreasing the glomerular filtration, neuro-modulation during the sleep-wake cycle, anti-
inflammatory action, effects on the heart including chronotropy, ionotropy and the 
regulation of the vascular tone (Fredholm, 2007). 
Generation of adenosine and its metabolism 
Adenosine is released when the cells are metabolically stressed either through an 
equilibrative transporter on the cell or as a result of cell damage (Abbracchio et al., 2003). 
At intracellular and extracellular sites, adenosine can be formed by enzymatic hydrolysis 
from two different substrates. The first pathway, 5’ nucleotidase hydrolyzes adenosine 
monophosphate (AMP) to adenosine (Frick and Lowenstein, 1976; Newby et al., 1985). 
Adenosine can also be synthesized by the action of S-adenosylhomocysteine hydrolase 
(SAH) on S-adenosylhomocysteine (Schutz et al., 1981).  SAH is tightly bound to 
adenosine and prevents its breakdown by adenosine deaminase (ADA) to inosine and the 
latter is finally broken down to uric acid and excreted in the urine (Lloyd and Fredholm, 
1995). In another pathway, adenosine is re-converted to AMP by adenosine kinase (AK).  
In addition to being metabolized, adenosine uptake into cells occurs by either a carrier 
system or a sodium-ribonucleside co-transport system. Once adenosine enters the cell, it 
binds to its receptors and exerts various physiological effects.  
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Figure 1.1: Structure of Adenosine 
Figure 1.2: Metabolism of Adenosine (Vallon et al., 2006) 
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Vascular tone 
The contractile state of the smooth muscle cell is defined as the vascular tone. The 
smooth muscle of the blood vessel exists in a partial contracted state; this tone increases 
as the diameter of the vessel decreases. This tone is independent of any hormonal or 
neural influences as there are sufficient calcium (Ca2+) channels on the membrane to 
maintain the partial contracted state. In addition, the norepinephrine (NE) released from 
sympathetic fibers further augments the vascular tone (Sherwood Lauralee, Human 
Physiology Cells to Systems, 7e;(Jackson, 2000).  
However, the vascular tone can be regulated by a complex interplay of 
contracting and relaxing factors, hormones, neurotransmitters, and endothelium -derived 
hyperpolarizing factors (EDHF). The contraction and relaxation of the smooth muscle is 
determined by the movement of ions through the ion channels on the plasma membrane.   
The role of various contracting and dilating factors and ion channels with focus 
on adenosine and large conductance potassium (BK) channels in the regulation of 
vascular tone has been discussed in subsequent sections. 
Adenosine Receptors 
Adenosine exerts its physiological effects by binding to one of its four G-protein 
coupled receptors: A1, A2A, A2B and A3. These glycoproteins have in common a central 
core of seven transmembrane spanning domains, and each transmembrane is composed of 
20-27 amino acids and with 3 extracellular and intracellular loops (Fredholm, 2007). The 
intracellular loops, extracellular amino (NH2) and the intracellular carboxy (COOH) 
termini differ in their length, function and sequence variation and are responsible for the 
specific properties of these receptor proteins. Apart from A2AR, all other receptors have 
cysteine residue in the COOH terminus for receptor palmitoylation. All the ARs are 
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glycosylated on their second extracellular loop (Moro et al., 2006). Each of these 
receptors has their own pharmacological profile, affinity to adenosine, tissue distribution 
and effector coupling. The receptors derive their name due to their affinity to adenosine, 
which acts as a full agonist at all the four receptors (Fredholm et al., 2001). Adenosine 
receptors are classified based on their ability to activate or inhibit adenylyl cyclase (AC) 
and regulation of the cyclic adenosine monophosphate (cAMP) levels.  
A1 adenosine receptor (A1AR): It inhibits AC through inhibition of pertussis toxin 
sensitive Gi proteins and decreases the cAMP levels and results in an increased activity of 
phospholipase C (PLC) activity (Rogel et al., 2005; Tawfik et al., 2005). In cardiac 
muscle and neurons, A1 receptor can activate potassium channels (K+) and inhibits Q-, P- 
and N-type Ca2+ channels (Fredholm et al., 2001). A1 couples with K+ channels and is 
responsible for the bradycardiac effect of adenosine on heart function. 
A2 adenosine receptor (A2AR and A2BR): It stimulates the AC and increases the cAMP 
levels through the cholera toxin sensitive GS protein in the peripheral system and in the 
striatal system A2AR mediates effects through Golf.  It has anti-inflammatory and 
vasodilatory role through the activation of PLC.  The A2B receptor signals through Gs/q 
and its activation can either result in increased cAMP or inositol,1,4,5- triphosphate (IP3)/ 
diacylglycerol (DAG) and Ca2+ levels.  Our lab has   shown previously that A2B mediates 
relaxation in mouse aorta through nitric oxide (NO) in the endothelium (Ansari et al., 
2007a)  
A3 adenosine receptor: A3 receptors are negatively coupled to AC and decrease cAMP 
levels. They also stimulate PLC pathway and aid in mobilizing Ca2+ (Jacobson and Gao, 
2006).  In cardiac cells, they provide protection through ATP sensitive K+ (KATP) channel 
activation (Tracey et al., 1998). A3 mediates vasoconstriction through the endothelial 
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dependent cyclooxygenase (COX) pathway and involves nicotinamide adenosine 
dinucleotide phosphate (NADPH) oxidase (Nox-2) (Ansari et al., 2007b; El-Awady et al., 
2011).   
The current thesis focuses on the role of A1AR in vascular tone regulation. 
Role of A1 AR in regulation of vascular tone 
A1AR is a 36 kDa protein found in highest density in the kidney, atria and in lower 
density in ventricles, lung, pancreas, liver and gastrointestinal tract (GI).  The third 
intracellular loop and the COOH terminus of the receptor influence the coupling of A1AR 
to Gi (Tucker et al., 2000). Furthermore, the coupling of the A1AR is affected by the 
composition, prenylation state and phosphorylation state of G protein γ subunits (Yasuda 
et al., 1996; Yasuda et al., 1998). The cytoplasmic domain of the receptor has several 
serine and threonine residues, which are potential sites for protein kinase A (PKA), 
protein kinase C (PKC) and β-adrenoreceptor kinase-mediated phosphorylation and may 
play a role in receptor desensitization (Nell and Albrecht-Kupper, 2009). It is well 
accepted that adenosine mediates contraction of the smooth muscle in several vascular 
beds. Activation of adenosine A1 receptors induces contraction through a COX dependent 
pathway in pulmonary artery (Biaggioni et al., 1989). Similar results were seen in guinea 
pig and feline pulmonary vasculature (Szentmiklosi et al., 1995; Cheng et al., 1996).  
A1AR activation leads to IP3 in rabbit airway smooth muscle and negatively modulates 
the vascular tone (Abebe and Mustafa, 1998). Adenosine at low concentrations contracts 
the afferent arterioles through A1AR activation. However at higher concentrations, 
adenosine has been shown to mediate vasodilation of the afferent arterioles through A2A, 
which is coupled to KATP channel (Tabrizchi and Bedi, 2001).   
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:  Figure 1.1: Structure of adenosine A1 receptor (Nell and Albrecht-Kupper, 2009) 
7 
 
Our lab provided the first evidence that A1AR negatively modulates the effect of 
adenosine on vascular tone in mouse aorta and coronary flow regulations (Tawfik et al., 
2005) resulting from activation of PLC pathway and Ca2+ mobilization (Tawfik et al., 
2005). Others have showed similar results in different vascular beds like human cultured 
prostatic stromal cells (Preston et al., 2004), cat esophageal smooth muscle cells (Shim et 
al., 2002), guinea pig aorta (Ford and Broadley, 1999) and mouse coronary artery cells, 
heart, aorta and carotid artery (Prentice et al., 2002; Talukder et al., 2002; Ansari et al., 
2009).  Though A1 is primarily known to mediate contraction, there are a few reports 
suggesting that A1 mediates vasodilation through KATP channel in the rat aortic 
endothelium (Ray and Marshall, 2006), in rat diaphragmatic arterioles (Danialou et al., 
1997), in the rat skeletal muscle (Bryan and Marshall, 1999), in pig coronary artery 
smooth muscle cells (Dart and Standen, 1993).  
Arachidonic acid metabolites 
A major component of the cell membrane phospholipid pool is the arachidonic 
acid (AA). This 20-carbon fatty acid when released from the membrane is catalyzed by 
several enzymes to numerous biological metabolites called eicosanoids. Apart from 
adenosine, AA metabolites can also regulate the vascular tone. It has long been known 
that AA can be metabolized by COX and lipoxygenases (LOX) to prostaglandins (PG), 
thromoboxane (TP), leukotrienes (LT), 5-, 12- and 15- hydroxyeicosatetraenoic acid 
(HETE). These metabolites play a significant role in pulmonary and renal function, 
vascular tone, and inflammation (Roman, 2002; Miyata and Roman, 2005). Cytochrome 
P450 enzymes  metabolize AA,  it was discovered thirty years ago (Chacos et al., 1982) 
and consists of two families: a) Cytochrome P-450-epoxygenases (Cyp epoxygenases) 
and b) ω-hydroxylases. Cyp epoxygenases catalyzes AA to epoxyeicosatrienoic acids 
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(EETs) and dihydroxyeicosatrienoic acids (diHETEs), while ω-hydroxylases metabolizes 
them to 19- and 20- HETEs and 7-, 10-, 12-, 13-, 15-, 16-, 17- and 18-HETEs from AA. 
These metabolites play a pivotal role as second messengers and paracrine factors in liver, 
kidney, blood vessels, lung, intestines, heart, pancreas and white blood cells and regulate 
pulmonary, renal, cardiac and vascular function and modulate inflammatory and growth 
responses (Capdevila et al., 1982; Randriamboavonjy et al., 2005).  
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 Figure 1.2: The enzymatic pathway of AA producing EETs and HETEs 
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EETs in the regulation of vascular tone 
Cyp epoxygenases produce EETs and belong to a conserved super-family of 
genes with a common evolutionary origin. Epoxygenase enzymes are present in the 
endothelial and vascular smooth muscle cells. Cyp2C and Cyp2J belonging to the Cyp 
epoxygenases family convert AA to 5,6-EET; 8,9-EET; 11,12- EET and 14,15-EET. The 
major CYP epoxygenases in humans are Cyp2C8, Cyp2C9 and Cyp2J2; in rats are 
Cyp2C11, Cyp2C23 and Cyp2J3; in mice are Cyp2C40, Cyp2C44, Cyp2C29, Cyp2J5 
(Fleming, 2001; Michaelis and Fleming, 2006).  
Studies in coronary, renal and cerebral vascular beds have shown that EETs 
increase the organ blood flow or cause vasodilation. Rodents, rabbits, canine and bovine 
blood vessels have also shown EET vasodilation (Imig et al., 2000; Fleming, 2001; 
Sudhahar et al., 2010). However, there are also studies showing where 5,6 EET and 8,9-
EET mediate vasoconstriction as these metabolites are also substrates for COX enzymes 
and bind to the TP receptors, activating it (Fulton et al., 1996; Imig and Navar, 1996).  
The main catabolic pathway for EETs is the conversion to diHETEs by soluble epoxide 
hyrdolase (sEH) enzyme. They can also be metabolized by ω-oxidation, β-oxidation and 
chain elongation; the latter two being more prominent when sEH activity is low or 
inhibited in the tissue (Carroll et al., 2006; Fleming, 2010). EETs are known to activate 
the BK channels in the smooth muscle resulting in cell membrane hyperpolarization and 
causing vasodilation. There is accumulating evidence that EETs activation of the BK 
channels in the smooth muscle requires Gαs and cAMP/ PKA (Li and Campbell, 1997; Li 
et al., 2002; Krotz et al., 2004; Fleming, 2010). However, studies in smooth muscle cells 
from rat cerebral arteries and mice mesenteric arteries suggest that EETs increase 
endothelial Ca2+ levels through activation of vanilloid type 4 transient receptor potential 
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(TRPV4) channels.  There are also reports that KATP channel contributes to EET mediated 
vasorelaxation (Imig, 2012; Ponnoth et al., 2012a). 
20-HETE in the regulation of vascular tone 
ω- hydroxylases consists of Cyp4a and Cyp4f families metabolize AA to 20-
HETE in the liver, kidney, heart, lung, brain and vasculature. There are several different 
isoforms encoded by cDNA in various species. In humans these are the Cyp4a11, Cyp4f2 
and Cyp4f3; in rats there are 4 of Cyp4a: Cyp4a1, Cyp4a2, Cyp4a3, Cyp4a8 and 4 Cyp4f 
isoforms: Cyp4f1, Cyp4f4, Cyp4f5 and Cyp4f6, and in mice Cyp4a10, Cyp4a12, and 
Cyp4a14 are expressed. Fibrates are known to induce Cyp4a1 and Cyp4a3 in the liver 
and kidney, but not in the blood vessels as they do not express peroxisome proliferator 
activated receptor (PPAR)-α  (Sundseth et al., 1992; Zhou et al., 2006).  The main 
pathway for their breakdown is by β-oxidation to less active shorter chain length products.  
The other pathways are metabolism by COX enzymes to form vasoconstrictor 
endoperoxides and vasodilator prostanoids (Schwartzman et al., 1989; Carroll et al., 
1992; Roman, 2002). 
 20-HETE is a potent vasoconstrictor of renal, cerebral, mesenteric and cardiac 
vascular beds (EC50<10-8M) (Ma et al., 1993; Imig et al., 1996; Zou et al., 1996). 
Angiotensin II (AngII), endothelin and serotonin (5-HT) stimulate the formation of 20-
HETE. Vasoconstrictor responses to these agonists are attenuated on inhibiting the 20-
HETE formation (Carroll et al., 1996; Oyekan et al., 1997; Alonso-Galicia et al., 1998; 
Alonso-Galicia et al., 1999; Croft et al., 2000). The production of 20-HETE is inhibited 
by NO, carbon monoxide and superoxide radicals (Roman, 2002). PKC, mitogen 
activated protein kinase (MAPK), src-type tyrosine kinase and rho kinase pathways are 
activated by 20-HETE and all play role in the regulation of vascular tone. Furthermore, 
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20-HETE increases the conductance of L-type Ca2+ channel and inhibits BK channels 
through PKC activation. This allows for sustained depolarization of vascular smooth 
muscle and Ca2+ entry through L-type Ca2+ channel and causes contraction of the smooth 
muscle (Zou et al., 1996; Lange et al., 1997; Sun et al., 1998; Sun et al., 1999; 
Gebremedhin et al., 2000). Recent studies have implicated that 20-HETE augments the 
activation of inward non-selective cation currents through transient receptor potential 
canonical 6 channels involved in myogenic response (Basora et al., 2003; Brayden et al., 
2008). 
Adenosine and Cyp450 metabolites in the regulation of vascular tone 
The interplay between adenosine and Cyp450 metabolites has come into light in 
past few years. Studies have shown a relationship between A2AAR and EETs.  In rat 
preglomerular vessels, A2AAR have shown to mediate vasodilation through EETs via 
cAMP-PKA pathway activating BK channels (Carroll et al., 2006). Inhibition of the 
EETs pathway with 14,15-EEZE (EETs antagonist) decreased the NECA-induced 
relaxation and showed contraction at higher doses in the A2AWT mice aortae as compared 
to the untreated control (Nayeem et al., 2008).  In addition, A1AR and Cyp4a protein has 
been shown to be up-regulated in A2AKO mice, suggesting a relationship between them 
(Ponnoth et al., 2012a). These findings have been discussed in the subsequent chapters.  
Potassium (K+) channels in the regulation of vascular tone 
There are several ion channels on the vascular smooth muscle cell surface. There 
are more than 4 types of K+ channels (Nelson et al., 1990; Nelson and Quayle, 1995; 
Jackson, 2000), 4 types  of voltage gated Ca2+channels, more than 2 types of Cl- channels, 
store-operated Ca2+ channels and stretch activated cation channels (Nelson et al., 1990; 
Jackson, 2000).  
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The most dominant ion channels are K+ channels and their activity plays a pivotal 
role in determining and regulating the membrane potential, thereby the vascular tone. 
There are 4 different types of K+ channels: voltage gated K+ (KV) channels, inward 
rectifier K+ (KIR) channels, KATP channels, and BK channels. This dissertation thesis 
focuses on role of BK channels in the regulation of vascular tone.  
a) KV channels: They are also known as delayed rectifier channels and are expressed 
on the smooth muscle. They are activated by membrane depolarization with 
threshold potentials of approximately 30mV for substantial activation. 
Vasoconstrictors have a tendency to close KV channels through PKC and 
intracellular Ca2+ and vasodilators open KV via cAMP signaling cascade (Nelson 
and Quayle, 1995). 
b) KIR channels:  These are found in both excitable and non-excitable cells.  The 
inward K+ current pass through these channels much more readily than the 
outward current with physiological ion gradients and with increase in extracellular 
K+ concentration increases the channel conductance. They are known to mediate 
vasodilation in cerebral, coronary, skeletal muscle vascular beds through elevated 
extracellular K+ resulting in hyperpolarization of vascular smooth muscle 
membrane and thereby dilation (Quayle et al., 1993). 
c) BK channels: These are found in vascular smooth muscle cells. As they allow the 
K+ channels to pass readily through them, they are also known as maxi-K 
channels or big K channels.  They have a conductance of 250pS and are activated 
by elevations in intracellular Ca2+ and membrane depolarization (Nelson, 1993). 
d)  KATP channels: These channels derive their name due to their sensitivity to 
intracellular ATP concentrations. They close as the ATP concentration increases. 
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Apart from smooth muscle; they are found in cardiac muscle, skeletal muscle, 
pancreatic β- cells and certain types of neurons (Nelson et al., 1990; Nelson, 
1993). 
BK channels in the regulation of vascular tone 
They are known as Slo 1 as they had been cloned from the drosophila slowpoke 
locus (Atkinson NS, Robertson GA and Gantetzky B; Science Wash. DC 253:551-555, 
1991).  BK channels are composed of 4 α subunits and 1-4 β-subunits (β1-β4). The pore 
forming α subunit is composed of 11 hyrdophobic domains (S0-S10), of which 
membrane spanning S0-S6 domains constitute the core region with an NH2 terminus and 
the remaining four domains (S7-S10) are located in cytoplasm and form the COOH 
terminus of the protein. The voltage sensor property of the channel is located on the S4 
domain and the pore forming region on the S5-S6 linker (Toro L, Taanaka Y News 
Physiol Sci 13:112-117, 1998).  The α subunit also contains the Ca2+ bowl in the tail 
region of the protein conferring the intrinsic sensitivity to Ca2+ to the protein. However, 
the regulator of conductance for K+ (RCK) domain present between the core and the tail 
region of the protein is also associated to Ca2+ sensitivity by some (Xia et al., 2002; 
Krishnamoorthy et al., 2005). The α subunit is encoded by Slo gene only, but has several 
subunits which confer different properties to the channels in various tissues like voltage 
sensitivity, phosphorylation by cAMP dependent PKA or PKG. The four-β subunits 
further add on to the variability as there are 4 subunit genes and 8 subunit proteins have 
been discovered with different pharmacological, modulatory effects and the activation 
gating of the channel.  The β subunit is composed of two transmembrane domains with 
an extracellular domain and cytoplasmic NH2 and COOH terminals.  It enhances the 
voltage and the calcium sensitivity of the channel by interacting with the S0 subunit and 
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NH2 terminus of the α-subunit. In vascular smooth muscle cells (VSMC) β1 is the 
prominent one. 
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Figure 1.3: Structure of BK channel (Ledoux et al., 2006) 
  
  
 
Figure 1.4: The native BK channel composed of 4-α and 4-β subunits (Ledoux et al., 2006) 
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Intracellular Ca2+ can cause dilation or constriction of the smooth muscle. A global 
increase in the cytoplasm Ca2+ concentration results in activation of the myosin light 
chain kinase (MLCK) and causes contraction of the smooth muscle. This global increase 
in calcium occurs through open state probability of the L-type voltage dependent calcium 
channel (L-VDCC) and regulated by the membrane potential and results in 
vasoconstriction. The Ca2+ increase from the ryanodine receptors (RyR)/ IP3 receptors, 
known as Ca2+ sparks, generates a highly localized elevation in the Ca2+ levels but the 
global Ca2+ level is raised minimally.  The IP3/ RyR receptors are located in close 
proximity to the BK channels and the Ca2+ sparks activates the BK channel (Perez et al., 
1999). Opening of the BK channels hyperpolarizes the membrane and promotes the 
closure of the L-VDCC and thus causing dilation.  Thus, the Ca2+ sparks opposes the 
vasoconstriction. 
BK channels play an important role in myogenic tone and contribute to the 
peripheral resistance. Several studies in rat cerebral, coronary and saphenous arteries 
have shown that increase in intracellular Ca2+ caused by pressure induced membrane 
depolarization and results in activation of BK (Brayden et al., 1991; Berczi et al., 1992).  
Adenosine and BK channels 
Adenosine relaxes vascular smooth muscle through several mechanisms, 
including the activation of K+ channels (Dart and Standen, 1993). Reports regarding the 
role of BK channels in adenosine-induced smooth muscle relaxation vary widely. In 
canine coronary arterioles, vasodilation in response to adenosine is inhibited by 
iberiotoxin (Cabell et al., 1994). Blocking BK channels inhibits vasodilation to 2-chloro-
adenosine in pig coronary arterioles (Borbouse et al., 2009); however, the role of BK 
channels in this response is abolished in pigs with metabolic syndrome (Borbouse et al., 
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2009). Thus, it could be pathology that explains why BK channels play no role in 
adenosine-induced vasodilation in human coronary arterioles (Sato et al., 2005), as they 
are typically collected from patients with heart disease. Conversely, it may be that BK 
channels play little, if any role, in adenosine-induced vasodilation, as this has been 
reported in the majority of studies from pig coronary arterioles (Hein and Kuo, 1999; 
Hein et al., 2001; Heaps and Bowles, 2002). However, it cannot be ignored that BK 
channels are reported to contribute to adenosine-induced relaxation/vasodilation of rat 
cerebral arterioles (Paterno et al., 1996), rabbit renal arteries (Rump et al., 1999); rat 
aortas (Ray and Marshall, 2006); and rat pre-glomerular microvessels (Carroll et al., 
2006). Further, adenosine increases a Ca2+-dependent K+ current in smooth muscle cells 
from the rat mesenteric artery that may be mediated by BK channels (Li and Cheung, 
2000). At present, there is little consensus regarding the role of BK channels in 
adenosine-induced smooth muscle relaxation and very little data directly addressing 
whether adenosine increases BK current in smooth muscle cells isolated from those same 
arteries or arterioles.  
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Specific Aims 
Adenosine plays an important role in the regulation of vascular tone in both 
physiological and patho-physiological conditions, where AR expression is altered.Apart 
from adenosine, the Cyp450 metabolites have also been shown to have pivotal role in 
the regulating the tone of the blood vessels.  Although the work  cited above provides 
evidence that A2A AR  and Cyp-epoxygenases-derived  metabolites (EETs) do interact, 
but the precise mechanism by which A1AR interacts with Cyp4a and regulate the 
vascular tone is completely unknown.  
Given the traits of A1AR and Cyp4a derived metabolite of AA (20-HETE), a 
relationship between the two is highly plausible.  Both A1AR and 20-HETE are 
altered in several pathophysiological conditions. Thus, understanding the 
relationship between the two will help to better develop therapeutic targets. Thus, 
the purpose of this dissertation is to identify the relationship between A1AR and 
Cyp4a and elucidate the signaling pathways in the regulation of vascular tone. 
With this in mind, the following aims were developed: 
Specific Aim1: To determine  elucidate the relationship between A1AR 
and Cyp4504a and in the A1AR mediated contraction of smooth muscle 
Working Hypothesis: Adenosine A1 receptor induced -vascular contraction is 
mediated through Cyp4504a metabolite, 20-HETE 
Specific Aim 2: To delineate the signaling pathways through which A1AR mediates 
vasoconstriction via 20-HETE 
Sub specific aim 2.1: To identify the signaling mechanisms of A1AR mediated smooth 
muscle contraction.  
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Working hypothesis: A1AR-20HETE mediates vasoconstriction through activation of 
PKC-α and p-ERK1/2 pathway. 
Sub-specific aim 2.2: To identify the ion channels involved in A1AR mediated 
contraction through 20-HETE 
Working hypothesis: In the presence of A1AR, 20-HETE modulates vascular response 
through BK channels in the aortic smooth muscle. 
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2. CHAPTER TWO: ADENOSINE A1 RECEPTORS LINK TO SMOOTH 
MUSCLE CONTRACTION VIA CYP4a, PKC-α AND ERK1/2 
 
 
Abstract 
Adenosine induces contraction of smooth muscle through A1 adenosine receptor 
(A1AR), possibly via generation of arachidonic acid-derived metabolite (20-HETE) 
by Cyp4a. 20-HETE is important in regulation of vascular tone. We tested the 
hypothesis that A1AR contraction of smooth muscle depends on Cyp4a through PKC-α- 
ERK 1/2 pathway. Experiments included isometric tension recordings of aortic 
contraction and Western blots of signaling molecules in wild type (WT) and A1AR 
knockout (A1KO) mice. Vascular responses for adenosine agonists and 20-HETE 
were obtained in both WT and A1KO mice aortae and mesenteric arteries. 20-HETE 
formation was evaluated in-vitro from WT and A1KO mice aortae.  In addition, 
vascular responses to adenosine agonists with Cyp4a inhibitor and to 20-HETE with 
PKC-α and ERK1/2 inhibitors were studied in mice aortae.  Immunoblots revealed 
higher Cyp4a levels in WT than A1KO.  HET0016 (Cyp4a inhibitor, 10-5M) 
dramatically reduced 5’-N-ethylcarboxamide adenosine (NECA, adenosine analog)-
induced contraction in WT (-4.02 ± 1.2% to 3.9 ± 0.7% at 10-6M, p<0.05), and 
enhanced relaxation in A1KO (16.1 ± 3.5% to 28.9 ± 6.6% at 10-6M, p<0.05).  Also, 2-
chloro-N6-cyclopentyladenosine (CCPA, an A1AR agonist)-elicited contraction was 
significantly blunted with HET0016 in WT (-36.1± 1.9% to -9.4 ± 2.9% at 10-6M, 
p<0.05) with no effect in A1KO.  20-HETE (10-7M) induced contraction was higher in 
WT than A1KO in aortae (33.4 ± 2.9% vs. 23.9 ± 2.4%) as well as mesenteric arteries 
(10.5 ± 1.52% vs. 0.3 ± 1.6%). This contraction was abated in WT and A1KO by 
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Gö6976 (PKC-α inhibitor) and PD98059 (ERK1/2 inhibitor). PKC-α, p-ERK1/2 and 
total ERK1/2 protein levels were higher in WT than A1KO (p<0.05), and Cyp2c29 
was upregulated in A1KO. Our data indicate that A1AR mediates smooth muscle 
contraction via CYP4a and a PKC-α-ERK1/2 pathway. These data suggest a 
relationship between A1AR and Cyp4a, and may have important implications in 
cardiovascular disorders. 
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Introduction 
Adenosine is an extracellular signaling molecule that affects heart rate, coronary 
blood flow, and blood pressure (Drury and Szent-Gyorgyi, 1929). Adenosine alters 
vascular tone by binding to one of the four G-protein coupled receptors: A1, A2A, A2B and 
A3. Activation of A1 and A3 receptors contracts vascular smooth muscle, in part, by 
inhibiting adenylyl cyclase through pertussis toxin-sensitive Gi protein (Abbracchio et al., 
1995; Tawfik et al., 2005; Jacobson and Gao, 2006). In contrast, activation of A2A and 
A2B receptors relaxes smooth muscle, in part, by stimulating adenylyl cyclase 
(Abbracchio et al., 1995). In the case of A2A, receptors, this process occurs through Gs and 
Golf proteins, whereas A2B receptors utilize Gs and Gq proteins (Abbracchio et al., 1995). 
In addition to G protein signaling, activation of adenosine receptors also leads to the 
metabolism of arachidonic acid and the production of myriad signaling molecules (Cheng 
et al., 2004). 
Metabolites of arachidonic acid regulate smooth muscle tone, including 
prostaglandins, thromoboxanes, leukotrienes, and hydroxyeicosatetraenoic acids 
(HETEs) (Hoagland et al., 2001; Roman, 2002; Miyata and Roman, 2005). Two 
subfamilies of cytochrome P450 (CYP) enzymes metabolize arachidonic acid: CYP-
epoxygenases and ω-hydroxylases (Miyata and Roman, 2005). The CYP-epoxygenases 
produce epoxyeicosatrienoic acids (EETs), which relax smooth muscle. In contrast, the 
ω-hydroxylases such as CYP4a and CYP4f produce 20-HETE, which contracts smooth 
muscle (Harder et al., 1994; Zou et al., 1996; Lange et al., 1997; Nayeem et al., 2008; 
Ponnoth et al., 2012a). The mechanisms linking CYP4a to smooth muscle contraction, 
however, are not entirely clear, especially in regard to adenosine A1 receptor activation. 
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20-HETE-induced contraction of smooth muscle appears to involve protein kinase 
C (PKC), Src-type tyrosine kinase, rho kinase and mitogen activated protein kinase 
(MAPK) pathways (Lange et al., 1997; Sun et al., 1999; Obara et al., 2002; Williams et 
al., 2010). We have demonstrated previously that A1 receptor stimulation is linked to 
PKC-α and ERK1/2 activation in coronary artery smooth muscle (Ansari et al., 2009). 
Gaps in our knowledge remain to be addressed, the most important of which pertain to 
whether A1 -dependent activation of PKC-α and ERK1/2 results in smooth muscle 
contraction. Thus, the aim of the present study was to delineate mechanisms downstream 
of A1 receptor activation that lead to smooth muscle contraction. We tested the 
hypothesis that adenosine A1 receptors contract smooth muscle through a pathway 
involving CYP4a, PKC-α, and ERK1/2. 
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Methods 
Animals: Some of the A1KO mice were obtained from Dr. Jurgen Schnermann 
(NIDDK, NIH) on C57BL/6 background. C57BL/6 (WT) mice were purchased from The 
Jackson Laboratory (Bar Harbor, ME). Equal number of males and females of 14-18 
weeks of age were used in our studies, as no gender differences were observed in the 
responses to the pharmacological agents used. The Institutional Animal Care and Use 
Committee of West Virginia University approved this study.  
Isometric tension: Following anesthesia with pentobarbital sodium (100 mg/kg, 
i.p.), the aorta was removed and cut into 3-4 mm rings. Rings were mounted on stainless 
steel wires and suspended in 10 ml organ baths filled with Krebs-Henseleit buffer 
containing (in mM): 118 NaCl, 4.8 KCl, 1.2 MgSO4, 1.2 KH2PO4, 25 NaHCO3, 11 
glucose and 2.5 CaCl2. Baths were maintained at 37°C and bubbled with 95% O2 and 5% 
CO2 (pH 7.4). Rings were equilibrated for 90 min under a resting tension of 1 g. Rings 
were contracted with 50 mM KCl twice to check viability. Rings were then treated with 
submaximal phenylephrine (PE; 1 µM) to obtain a stable contraction and integrity of the 
vascular endothelium was confirmed by relaxation to acetylcholine (1 µM). Tension was 
monitored continuously with a digital acquisition system and analyzed using 
Acknowledge 3.5.7 software (BIOPAC). Our laboratory previously validated all methods 
(Tawfik et al., 2005; Ansari et al., 2007a; Ponnoth et al., 2008; Ansari et al., 2009).  
Concentration-response curves for 5'-N-ethylcarboxamido adenosine (NECA; 10-
11
-10-5M), 2-chloro-N (6) cyclo-pentyl-adenosine (CCPA; 10 pM to 10 µM) were run in 
parallel in aortic rings from WT and A1KO mice. In all experiments, drugs were 
administered to yield the next higher concentration only when the previous response 
reached steady state. 20-HETE (Cayman Chemical; Ann Arbor, MI) concentration-
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response curves were constructed, but in some experiments a single concentration (100 
nM) was used as described previously (Alonso-Galicia et al., 1998; Obara et al., 2002; 
Wu and Schwartzman, 2011; Singh et al., 2012). Inhibitors of CYP4a (HET0016; 
Cayman Chemical), PKC-α, (Gö6976; Calbiochem; La Jolla, CA), and ERK1/2 
(PD98059; Calbiochem) were added 30 min prior to contraction with PE (10-6M) and 
present throughout the experiments. Inhibitor concentrations were determined by others 
and us (Loufrani et al., 1999; Ansari et al., 2001; Cogolludo et al., 2003; Ding et al., 
2004; Sakwe et al., 2005; Nayeem et al., 2008; Ansari et al., 2009; Chang et al., 2009; 
Matsumoto et al., 2011; Ponnoth et al., 2012a). Acetylcholine and PE were dissolved in 
distilled water, while NECA, CCPA, HET0016, Gö6976, and PD98059 were dissolved in 
DMSO. We have shown that previously these vehicles have no effect on smooth muscle 
contraction (Ansari et al., 2007a). 20-HETE was dissolved in ethanol and had no effect 
on the vasoconstrictive properties of the drug. Percentage of contraction was determined 
as a percent change from the maximum phenylephrine (PE) response. If A = maximum 
total tension in the presence of PE; B = maximum total tension when a drug is added after 
PE; C = minimum passive tension determined after the experiment, after a final wash; D 
= PE-induced active tension = A minus C. Thus, % contraction = [(B – A) / D] X 100% 
Immunoblots:  Aortae from WT and A1KO mice were homogenized with 150 µL 
RIPA, (Cell Signaling Technology); 20 mM Tris-HCl (pH 7.5),(150 mM NaCl, 1 mM 
Na2EDTA, 1 mM EGTA, 1% NP-40, 1% sodium deoxycholate, 2.5 mM sodium 
pyrophosphate, 1 mM beta-glycerophosphate, 1 mM Na3VO4, 1 µg/ml leupeptin), 
vortexed, and centrifuged for 10 min at 13,800 g at 4°C. Supernatants were stored at -
80°C. Protein was measured using the Bradford dye procedure with bovine serum 
albumin (BSA) as a standard (Bio-Rad Laboratories; Hercules, CA). The protein extract 
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was divided into aliquots and stored at -80°C. Samples (25 µg of total protein) were 
loaded on slab gels (10% acrylamide; 1 mm thick), separated by SDS-PAGE, and 
transferred to nitrocellulose membranes (Hybond-ECL). Protein transfer was confirmed 
by visualization of prestained molecular weight markers (Bio-Rad). Membranes were 
blocked with 5% nonfat dry milk and incubated with primary antibody. 1:1000 dilutions 
were used for CYP4a (Abcam; Cambridge MA) and PKC-α (BD Transduction Labs; San 
Diego, CA) antibodies, while 1:500 dilutions were used for total ERK1/2 and p-ERK1/2 
(both from Santa Cruz Biotechnology; Santa Cruz, CA) and 1:5000 for Cyp2c29 (Dr. 
Darryl C. Zeldin(NIH/NIEHS)). The phospho-ERK1/2 blots were stripped at room 
temperature for 15 minutes and re-probed for total-ERK1/2. All membranes were 
stripped and probed for β-actin (Santa Cruz); this served as an internal control to 
normalize protein expression in each lane. Secondary antibodies were horseradish 
peroxidase-conjugated. Membranes were developed using enhanced chemiluminescence 
(AmershamBioSciences) and X-ray film. 
Measurement and analysis of 20-HETE formation rates 
 
Equal numbers of male and female aortae were isolated on ice from WT and 
A1KO mice. Microsomes were prepared by pooling the aortae and homogenizing in 
50mM/L Tris buffer (pH7.4) containing 150mM KCl, 0.1mM DTT, 1mM EDTA and 
20% glycerol. Each sample consisted of six aortae (n=1). Microsomal fractions were 
isolated by differential centrifugation as previously described by us (Nayeem et al., 2008) 
and Dr. Poloyac’s group (Poloyac et al., 2006; Miller et al., 2009) .  Microsomal fractions 
containing 100µg total protein and 25µM AA were incubated in 1ml of 0.12M KH2PO4 
buffer containing 5mM MgCl2. Reactions were initiated by addition of 1mM NADPH at 
37°C for an hour and were terminated by placing the reaction tubes on ice. 0.75ng of 20-
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HETE d6 was added as an internal standard to each sample. HETE metabolites were 
separated along with others via reverse phase ultra-performance  liquid chromatography 
(UPLC; Milford,MA) with an Acquity UPLC BEH C18 1.7µM, 2/1x100 mm column as 
previously described (Miller et al., 2009).  Analysis was carried out on the TSQ operated 
in negative electrospray ionization-selected reaction monitoring mode with unit 
resolutions at both Q1 and Q3 set at 0.70 full width at half maximum. The selected 
reaction monitoring transitions that were monitored were as follows: 20-HETE mass-to-
charge ratio (m/z) 319.3 → 245.0; and 20-HETE-d6 (internal standard) m/z 325.3 → 
251.0. Collision energy was optimized for each transition and  ranged from 11 to 25eV 
with a total scan time of 0.01 s. Parameters were optimized to obtain the highest [M-H]+ 
ion abundance and were as follows: capillary temperature 270°C, spray voltage 3,800 kV, 
and source collision-induced dissociation set at 1 V. Sheath gas, auxiliary gas, and ion 
sweep gas pressures were set to 60, 50, and 0 psi, respectively. Collision gas pressure was 
set to 1.2 mTorr.  The data from two separate experiments have been combined for a 
significant ‘n’. 
Real Time PCR 
The aortic tissues from WT and A1KO were processed for total RNA isolation 
using the TRI reagent (MRC, Cincinnati, OH) followed by purification of the RNA in 
aqueous phase and removal of genomic DNA by an RNeasy Plus Micro Kit (QIAGEN, 
Hilden, Germany).This was followed by conversion of 0.5 g of total RNA into cDNA 
using High Capacity cDNA archive kit (Applied Biosystems, Foster City, CA) in a total 
volume of 20 µl. Real-time PCR was performed using an ABI PRISM 7300 Detection 
System (Applied Biosystems) using Taqman Universal Mastermix (Applied Biosystems, 
Branchburg, NJ) according to the instructions of the manufacturer. The reaction volume 
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(20 µl) consisted of 10 µl of 2X Taqman Universal Mastermix, 4 µl of cDNA, and 1 µl of 
20X FAM-labeled Taqman gene expression assay. For the real-time PCR of the 
concerned genes (Cyp4a10, A1AR, A2AAR,A2BAR and A3AR ), the Taqman inventoried 
assays on-demand gene expression products  were purchased from Applied Biosystems 
(Foster City, CA). 18S rRNA (ribosomal RNA) was used as an endogenous control. The 
fold difference in expression of target cDNA was determined using the comparative cycle 
threshold (Ct) method as described earlier(Livak and Schmittgen, 2001). 
Statistical Analysis: Data are expressed as mean ± SEM from n number of mice. 
Concentration-response curves and 20-HETE/inhibitor experiments were analyzed by 2-
way analysis of variance (ANOVA). Comparisons of two densitometry values were made 
with unpaired t-tests. P < 0.05 was considered significant in all tests. 
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Results 
Cyp4a protein levels in WT and A1KO mice: 
Immunoblot analysis showed a ~25% decrease in Cyp4a protein levels in A1KO as 
compared to WT (74.5 ± 3.7% vs. 100 ± 10.61%, Fig. 2.1A). However, there was no 
difference in Cyp4a10 mRNA levels (Fig 2.1B) 
 
Effect of Cyp4a inhibitor (HET0016) on NECA and CCPA induced vascular 
responses in aorta: 
To verify if Cyp4a plays a role in A1AR mediated vasoconstriction, we investigated the 
effect of Cyp4a inhibitor, HET0016 on NECA (a non-selective adenosine agonist) and 
CCPA (an A1AR agonist)-induced vascular responses. We found that NECA-elicited 
contraction in WT (-4.02 ± 1.2%; 10-6M; Fig. 2.1A; closed squares) was changed to 
significant relaxation in the A1KO mice (16.1 ± 3.5%; 10-6M; Fig 2.1A; closed circles). 
Relative to the WT mice, HET0016 alleviated the NECA-induced contraction (3.97 ± 
0.7%; 10-6M; Fig 2.1A; open squares). Similarly, in A1KO mice, Cyp4a inhibition 
enhanced the relaxation from 16.05 ± 3.5% to 28.96 ± 6.6% (fig2.1A; open circles) 
compared to the litter-matched controls at 10-6M NECA (Fig 2.1A). There was a 
significant difference between the treated WT and A1KO with HET0016 (3.97 ± 0.7% vs. 
28.96 ± 6.6%; 10-6M NECA; Fig 2.1A). CCPA-evoked contraction in the WT (-36.1 ± 
1.9%; 10-6M; Fig 2.2B; open circles) was significantly changed to relaxation in the A1KO 
(11.4 ± 8.5%; 10-6M; closed circles). Pharmacological inhibition of Cyp4a (HET0016) 
blunted the CCPA induced contraction by 26.7% from -36.1 ± 1.9% to -9.4± 2.9% 
(p<0.05) at 10-6M in WT mice (Fig 2.2B; open squares). CCPA induced vascular 
responses were unaltered in both the treated and untreated A1KO littermates as shown in 
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Fig 2.2B (closed squares). However, on treatment with the Cyp4a inhibitor, the CCPA 
response showed higher relaxation in A1KO (11.3 ± 8.5%; 10-6M) as compared to WT (-
9.4 ± 2.9%; 10-6M). ACh-induced response in WT (47 ± 2%) was not significantly 
different from A1KO (51 ± 3%, p>0.05) (Fig 2.2C). These results are consistent with 
those demonstrated by Wang Y et al (Wang et al., 2010)in mouse aorta 
 
Effect of 20-HETE on vascular responses, and 20-HETE formation rates in A1KO 
and WT animals: 
We further investigated the effect of 20-HETE on vascular responses in both WT and 
A1KO mice aortae and mesenteric arteries, and determined the in vitro 20-HETE 
formation rate in WT and A1KO aortic microsomes. As shown in Fig 2.3E., 20-HETE 
elicited vasoconstriction in the WT, showed similar trend of being significantly higher in 
both the aortae (59.18±6.09% vs. 41.32±4.49%) and the mesenteric arteries (10.2±1.52% 
vs. 0.3±1.6%), compared to A1KO mice. We observed an unexpected increase in the 
contraction on addition of lowest concentration of 10-11M 20-HETE in both WT and 
A1KO (Fig. 2.3D) mice aortae. Furthermore, 20-HETE formation rate was observed to be 
significantly higher in aortic microsomes from WT (0.31±0.012 pg/mol/min) than the 
A1KO (0.23±0.018 pg/mol/min; Fig 2.4). 
 
Cyp2c29protein levels in WT and A1KO mice: 
Measurement of Cyp2c29 showed an up-regulation of the protein by 73% in A1KO mice 
aortae, relative to its WT counterpart (172.7 ± 12.1%vs. 100 ± 23.04%, Fig 2.5A). 
Subsequently, we determined the effect of Cyp-epoxygenases inhibition on CCPA 
induced aortic response. In the WT littermates, MSPPOH (Cyp-epoxygenases  inhibitor; 
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10-5M), increased  the CCPA-induced contraction by 15.3% from -32.5 ± 1.7% to  -47.8.4 
± 6% at 10-7 M (Fig. 4). Likewise, in A1KO mice, MSPPOH treatment increased the 
vascular response by 19.3% from 5.8 ± 4 % to -13.5 ± 7.4% at 10-7M (Fig. 2.5B).  
Role of PKC-α in 20-HETE-induced contraction 
20-HETE (100 nM), a CYP4a product, contracted aortae from WT and A1KO mice (Fig. 
2.6B); however, the contractile response was less in aortic rings from A1KO mice. 
Inhibition of PKC-α (100 nM Gö6976) reduced 20-HETE-induced contraction in aortic 
rings from both WT (by 37%) and A1KO (by 29%) mice (Fig. 2.6B). The relative 
inhibitory effect of Gö6976 was the same in aortic rings from WT and A1KO mice (Fig. 
2.6C). PKC-α protein was expressed in aortae from WT and A1KO mice (Fig. 2.6A); 
however, the expression of PKC-α was lower (by 47%) in A1KO mice (p<0.05). 
Role of ERK1/2 kinase in 20-HETE-induced contraction 
The CYP4a product 20-HETE (100 nM) contracted aortic rings from both WT and A1KO 
mice (Fig. 2.7B); however, the contractile response was less in aortae from A1KO mice. 
Inhibition of ERK1/2 (1 µM PD98059) reduced 20-HETE-induced contraction in aortae 
from WT (by 48%) and A1KO (by 36%) mice (Fig. 2.7B). The relative inhibitory effect 
of PD98059 was similar in aortic rings from WT and A1KO mice (Fig. 2.7C). ERK1/2 
protein was expressed in aortae from WT and A1KO mice (Fig. 2.7A); however, the 
expression of total ERK (by 35%) and phospho-ERK (by 15%) were lower in A1KO mice  
(p<0.05). 
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Figure 2.1: Cyp4a protein and mRNA levels in WT and A1KO. 
Western blots for CYP4a expression in the aorta (A). Mouse isoform Cyp4a10 levels in 
WT and A1KO mice aortae (B). Data are expressed as mean ± SEM; n=6-8mRNA level. 
*p < 0.05 between WT and A1KO 
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Figure 2.2: Effect of Adenosine Receptor agonists’ and acetylcholine -induced 
responses in WT and A1 KO aortae and mesenteric arteries 
 
(A) Non selective adenosine agonist NECA mediated responses with Cyp4a inhibitor (10 
µM HET0016); +p<0.05 between A1KO and WT; *p<0.05 between WT +HET0016 and 
WT; #p<0.05 between A1KO + HET0016 and WT + HET0016; $p<0.05 between A1KO + 
HET0016 and A1KO. Data are expressed as mean ± SEM (n=6-12); (B) The A1-selective 
agonist CCPA-mediated contractions with CYP4a inhibitor (10 µM HET0016), *p < 0.05 
between WT and A1KO and †p < 0.05 between WT and WT + HET0016 (n=4-12). (C) 
Acetylcholine (ACh) responses in WT and A1KO mice aortae and mesenteric arteries 
responses. *p < 0.05 between WT and A1KO (n=6-12). 
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Figure 2.3: Effect of the CYP4a product, 20-HETE on smooth muscle contraction 
from WT and A1KO mice. 
 
(A) Representative traces for concentration response curve for solvent (ethanol) in WT 
mice aortae (n=4). (B) Representative traces for concentration response curve for 20-
HETE in WT mice aortae. (C) Representative traces for concentration response curve for 
20-HETE in A1KO mice aortae. (D) Exogenous 20-HETE contracts aortic smooth muscle 
in a concentration-dependent manner. *p < 0.05 between WT and A1KO mice (n=8-12) 
(E) Exogenous 20-HETE responses in aortae and mesenteric arteries. Data are expressed 
as mean ± SEM (n=8). *p<0.05 compared to the WT in the respective tissue 
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Figure 2.4: 20-HETE formation rate in microsomes from WT and A1KO mice 
aortae (n=6-8) 
Data are expressed as mean ± SEM. 
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Figure 2.5: Role of Cyp2c29 in WT and A1KO  
(A) Cyp2c29 protein levels in aortae from WT and A1KO. Data are expressed as mean 
±SEM and are presented as representative blot from 6 individual samples, *p<0.05 as 
compared to WT (B) Effect of Cyp–epoxygenase inhibitor (MSPPOH; 10-5M) on CCPA 
induced vascular response: Data are expressed as mean ± SEM (n=10). * p<0.05 
compared to the WT, #p<0.05 compared to WT + MSPPOH, $p<0.05 compared to A1KO. 
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Figure 2.6: Effect of on PKC-α on WT and A1KO contractile responses to 20-HETE.  
 
(A) Western blots for PKC-α protein and β-actin; (B) Aortic smooth muscle contractions in 
response to 100 nM 20-HETE are shown for WT and A1KO mice with or without inhibition 
of PKC-α (100 nM Gö6976); (C) The inhibitory effect of Gö6976 on 20-HETE-induced 
contractions is equivalent in WT and A1KO mice, suggesting that the relative importance of 
PKC-α is unchanged. Data are expressed as mean ± SEM; n = 6-16 mice; *p< 0.05 between 
WT and A1KO; †p < 0.05, WT, A1KO vs. WT + Gö6976 & A1KO+ Gö6976. 
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Figure 2.7 Effect of ERK 1/2 on WT and A1KO mice aortae contractile responses  
(A) Western blots for total ERK1/2, phosphor-ERK1/2 and β-actin expression in the 
aorta; (B) Aortic contractile responses to 100 nM 20-HETE are shown for WT and A1KO 
mice with or without inhibition of ERK1/2 (1 µM PD98059); (C) The inhibitory effect of 
PD98059 on 20-HETE-induced contractions.  n=8-16*p < 0.05 between WT and A1KO; 
‡p < 0.05, WT, A1KO vs. WT + PD98059 & A1KO+ PD98059, respectively.  
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Figure 2.8 Adenosine A1 receptors link to smooth muscle contraction via CYP4a, 
PKC-α, and ERK1/2.  
This figure illustrates our understanding of signaling from the A1 receptor to smooth 
muscle contraction. Adenosine A1 receptors (A1R) are sensitive to CCPA and coupled to 
phospholipase C (PLCX) by G-proteins (GX). Candidates for PLCX include PLCβ1, 
PLCβ3, and PLCγ1, while candidates for GX include Gi, Go, Gq, G11 as well as G-βγ 
subunits (Jacobson and Gao, 2006; Ansari et al., 2009). PLCX produces two second 
messengers from phosphatidylinositol 4,5 bisphosphate: diacylglycerol (DAG) and 
inositol 1,4,5-trisphosphate (IP3, which releases Ca2+ from the sarcoplasmic reticulum; 
SR). DAG can be metabolized by di- and monoacylglycerol lipases to produce 
arachidonic acid (AA). CYP4a metabolizes AA into 20-HETE, which activates PKC-α 
(DAG is also an activator; PKC- β and γ isoforms are also expressed (Ansari et al., 2009). 
The ERK1/2 pathway is activated downstream of PKC-α. The culmination of this 
signaling is to contract smooth muscle through effects on, e.g., myosin light chain kinase 
(MLCK), myosin light chain phosphatase (MLCP), and thin filament regulatory proteins. 
Inhibiting CYP4a with HET0016 blocks CCPA-induced smooth muscle contraction (Fig. 
2.1 and 2.2). Gö6976 and PD98095, which inhibit PKC-α and ERK1/2, inhibit smooth 
muscle contraction in response to 20-HETE (Fig. 2.6 and Fig 2.8)  
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Discussion 
It is well documented that A1AR on activation mediates vasoconstriction 
through Gi and Go proteins(Jacobson and Gao, 2006). Our data show that NECA -
evoked contraction in WT was lower in the A1KO mice aortae (Fig. 2a). We also 
observed in the aortic tissue that CCPA-induced contraction was completely 
abolished in A1KO (Fig. 2b). Our results are consistent with previous findings from 
our laboratory and others (Tawfik et al., 2005; Wang et al., 2010) . We have found 
that NECA and CCPA induced responses in the mesenteric arteries are similar to 
those found in the aortae as reported earlier from our laboratory (Teng et al., 
2011).The contractile responses elicited by these adenosine agonists are similar to 
those found in a wide variety of systems like mouse afferent arterioles (Hansen et al., 
2003), human cultured prostatic stromal cells (Preston et al., 2004), cat esophageal 
smooth muscle cells (Shim et al., 2002), guinea pig aorta (Ford and Broadley, 1999)  
and mouse coronary artery cells, heart, aorta and carotid artery (Prentice et al., 
2002; Talukder et al., 2002; Ansari et al., 2009) 
The first evidence of an interaction between A1AR and Cyp4a is the 
significantly lower levels of Cyp4a protein expression in the A1KO mice as compared 
to the WT (Fig.1). To further examine, the functional interplay between Cyp4a and 
A1AR, we studied the effect of Cyp4a inhibition on adenosine agonists’ elicited 
contractile responses in WT and A1KO mice aortae. Due to the similar responses to 
adenosine agonists in the mice mesenteric arteries and aortae, we used aortae for 
these studies. HET0016 dramatically reduced the contraction responses induced by 
NECA, in both the WT and the A1KO mice aortae (Fig. 2a). Moreover, there was a 
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significantly higher relaxation observed in NECA-induced aortic responses in A1KO 
with the pharmacological inhibition of Cyp4a (Fig. 2a).This suggested that Cyp4a 
may play a part in the A1AR mediated vasoconstriction. The above findings were 
confirmed when Cyp4a inhibitor, HET0016 attenuated the vasoconstriction evoked 
by the A1 agonist, CCPA in the WT with no significant difference in the treated 
(HET0016) and untreated A1KO tissues (Fig. 2b). However, we observed a 
significant difference in both the NECA and CCPA induced vascular responses in the 
HET0016 treated WT and A1KO tissues (Fig 2). These results clearly implicate a role 
for Cyp4a in A1AR mediated vasoconstriction. These findings are congruent with 
previous studies in our lab (Nayeem et al., 2009) and others as well, which have 
shown an inhibition of Cyp4a with HET0016 in renal interlobar arteries from 
Sprague Dawley rats (Sodhi et al., 2010) and human and rat cerebral arteries(Toth 
et al., 2011). 
20-HETE is a potent vasoconstrictor of renal, mesenteric, skeletal and 
cerebral arterioles across several species (Roman, 2002). Several investigators have 
shown that in both circulatory and pulmonary vascular beds, 20-HETE mediates 
vasoconstriction by uncoupling of nitric oxide synthase, resulting in reduction of 
endothelial dependent relaxation (Frisbee et al., 2000; Singh et al., 2007; Cheng et al., 
2008). Our data show that 20-HETE vascular responses in aortae and mesenteric 
arteries are lower in A1KO as compared to the WT (Fig.3a). Moreover, the Cyp4a 
functional activity evaluated by the 20-HETE formation rates in the aortic 
microsomes were found to be lower in the A1KO (Fig 3b) as compared to the WT 
mice. This further underscores the role of Cyp4a in A1AR mediated vasoconstriction. 
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There is a dynamic interplay between the metabolites of the two pathways of 
Cyp450 enzymes, EETs and 20-HETEs, in the modulation of vascular homeostasis. EETs 
are considered to be endothelium-derived hyperpolarizing factors that induce 
hyperpolarization of the endothelial cells and vascular smooth muscle cells resulting in 
vasodilation. 20-HETE in vascular smooth muscle causes vasoconstriction by 
depolarization of vascular smooth muscle cell (Miyata and Roman, 2005)(Miyata and 
Roman, 2005)(Miyata and Roman, 2005). As Cyp4a and Cyp2c products have 
functionally antagonistic effects, we investigated if Cyp2c29 has any relationship to the 
A1AR mediated vascular responses. We observed that Cyp2c29 protein levels were 
significantly up- regulated in A1KO mice as compared to the WT (Fig S.3.5). Since we 
have seen an up-regulation of Cyp2c29 in A1KO compared to WT mice, it is quite 
possible that relaxation observed in A1KO mice by Cyp4a inhibition is due to Cyp2c29 
product EETs and due to the inhibition of Cyp4a that limits the production of 20-HETE. 
This observation was confirmed by the enhanced CCPA mediated vasoconstriction in the 
presence of the Cyp-epoxygenase inhibitor, MSPPOH (Fig.S.3.6). We have shown earlier 
that Cyp4a protein levels are up regulated with MSPPOH treatment (Nayeem et al., 2008). 
In the WT, although Cyp-epoxygenases were inhibited, a higher contraction observed 
with MSPPOH treatment is due to higher levels of Cyp4a and in the A1KO, the higher 
vascular response is due to inhibition of the Cyp-epoxygenases. Thus, the down-
regulation of Cyp4a and an up-regulation of Cyp2c29 protein levels promote the 
relaxation observed in the A1KO littermates. This inverse relationship between Cyp4a 
and Cyp2c is consistent with findings from other investigators in rat afferent arterioles 
and preglomerular arterioles (Hercule and Oyekan, 2000; Imig et al., 2000). 
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Several studies have reported that 20-HETE promotes constrictor responses 
by activating PKC, Src type tyrosine kinase, rho kinase and the MAPK pathways 
(Lange et al., 1997; Sun et al., 1999; Obara et al., 2002; Williams et al., 2010). 
Moreover, adenosine subsequent to binding to its receptors induces signaling 
cascades by activating MAPK through G-protein coupled mechanism. In addition, 
our laboratory has shown that in mouse coronary artery smooth muscle cells, A1AR 
mediates vasoconstriction through PKC-α, leading to phosphorylation of p42/44 
mitogen activated protein kinase (MAPK) via PLC β-III (Ansari et al., 2009). Given 
this evidence, we investigated the effect of PKC-α and ERK1/2 inhibition on 20-
HETE induced contraction in both WT and A1KO mice. The basal protein levels of 
PKC-α, p-ERK1/2 and total ERK1/2 are higher in the WT as compared to the 
knockout littermates (Figs. 5 and 7). The lower PKC-α and p-ERK1/2 protein levels 
in the A1KO mice are consistent with our previous findings in the A1KO mouse 
coronary artery smooth muscle cells (Ansari et al., 2009). Exogenous administration 
of 20-HETE produced similar higher contraction response in WT than the A1KO, 
both in the mice aortae and mesenteric arteries (Fig 3), thus, suggesting that the 
signaling proteins downstream of 20-HETE are essential in Cyp4a modulation of 
A1AR mediated vasoconstriction. The use of a specific PKC-α blocker, Gö6976, 
attenuated the 20-HETE mediated vasoconstrictor response in WT and A1KO mice 
aortae (Fig. 6). Similarly, pharmacological inhibition of ERK1/2 with PD98059 
decreased the 20-HETE-elicited contraction in the WT and almost abolished the 
contractile tone in the A1KO (Fig. 8). However, the greater blockade of the 
vasoconstrictor responses with ERK inhibitor than with the PKC-α inhibitor implies 
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that MAPK pathway activation may involve several kinases like PKA, PKC, rho 
kinases or Ras activation or a cross talk between the different tyrosine kinase 
receptors. These data substantiate the role of PKC-α and ERK1/2 in A1AR mediated 
vasoconstriction through 20-HETE. 
Our current understanding of signaling for A1  CYP4a  PKC-α  ERK 
pathway is summarized in Fig. 4. A1 receptor activation with, e.g., CCPA, activates 
CYP4a which metabolizes AA into 20-HETE. CCPA-induced contractions are almost 
entirely dependent upon signaling through CPY4a, as inhibition with HET0016 abrogates 
contraction (Fig. 3.1A). 20-HETE activates PKC-α and this is integral to contraction, as 
Gö6976 blocks the response (Fig. 3.3). The ERK1/2 pathway is activated downstream of 
PKC-α, as Gö6976 blocks ERK activation (Ansari et al., 2009) and PD98059 blocks the 
contraction (Fig. 3.3). ERK1/2 integrates the signaling for contraction and transduces it to, 
e.g., myosin light chain kinase (MLCK), myosin light chain phosphatase (MLCP), and 
thin filament regulatory proteins.  
In summary, we have shown that A1 receptor activation leads to smooth muscle 
contraction via CYP4a, PKC-α, and ERK 1/2. Because A1 receptors and 20-HETE are 
implicated in a variety of cardiovascular disorders, a better understanding of this pathway 
will be important for identifying therapeutic targets and treatment opportunities.  
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3. CHAPTER THREE: ADENOSINE A1 RECEPTORS INHIBIT BK CHANNELS 
THROUGH PKC-α DEPENDENT MECHANISM IN MOUSE AORTIC SMOOTH 
MUSCLE CONTRACTION 
 
Abstract 
Adenosine receptors (AR; A1, A2A, A2B, and A3) contract and relax smooth muscle 
through different signaling mechanisms. Deciphering these complex responses remains 
difficult because relationships between AR subtypes and various end-effectors (e.g., 
enzymes and ion channels) remain to be identified. A1AR stimulation is associated with 
the production of 20-hydroxyeicosatetraenoic acid (20-HETE) and activation of protein 
kinase C (PKC). 20-HETE and PKC can inhibit large conductance Ca2+/voltage-sensitive 
K+ (BK) channels that regulate smooth muscle contraction. We tested the hypothesis that 
activation of A1AR inhibits BK channels via a PKC-dependent mechanism. Patch clamp 
recordings and Western blots were performed using aortae of wild type (WT) and A1AR 
knockout (A1KO) mice. There were no differences in whole-cell K+ current or α and β1 
subunits expression between WT and A1KO. 20-HETE (100 nM) inhibited BK current 
similarly in WT and A1KO mice. NECA (5'-N-ethylcarboxamidoadenosine; 10 µM), a 
non-selective AR agonist, increased BK current in myocytes from both WT and A1KO 
mice, but the increase was greater in A1KO (52±15 vs. 17±3%; p<0.05). This suggests 
that A1AR signaling negatively regulates BK channel activity. Accordingly, CCPA 
(2-chloro-N(6)-cyclopentyladenosine; 100 nM), an A1AR-selective agonist, inhibited BK 
current in myocytes from WT but not A1KO mice (81±4 vs. 100±7% of control; p<0.05). 
Gö6976 (100 nM), a PKCα inhibitor, abolished the effect of CCPA to inhibit BK current 
(99±3% of control). These data lead us to conclude that, in aortic smooth muscle, A1AR 
inhibits BK channel activity and that this occurs via a mechanism involving PKCα. 
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Introduction 
Adenosine exerts its effects through four G-protein coupled receptors: the known 
adenosine receptor (AR) subtypes are A1, A2A, A2B and A3. These AR subtypes play 
important roles in vascular reactivity, as A1AR and A3AR contract smooth muscle, 
whereas A2AAR and A2BAR relax smooth muscle (Fredholm et al., 2001; Tawfik et al., 
2005; Jacobson and Gao, 2006; Ansari et al., 2007b; Ponnoth et al., 2009). It is well 
accepted that metabolites of arachidonic acid (AA) regulate vascular tone; however, only 
recently have these pathways been recognized to function downstream of A1AR and 
A2AAR (Harder et al., 1997; Cheng et al., 2004; Nayeem et al., 2008; Ponnoth et al., 
2012a). Epoxyeicosatrienoic acids (EETs) and 20-hydroxyeicosatetraenoic acid (20-
HETE) are produced from arachidonate by epoxygenases and ω-hydroxylases, 
respectively. EETs are considered to be endothelium-derived hyperpolarizing factors that 
activate Ca2+-dependent K+ channels and Na+-K+-ATPase (Roman et al., 2000). 20-
HETE in vascular smooth muscle functions as a second messenger to promote 
depolarization, Ca2+ influx, and contraction of vascular smooth muscle that acts, in part, 
through protein kinase C (PKC) (Miyata and Roman, 2005; Williams et al., 2010). 
Ion channels are important determinants of vascular tone, as they control 
membrane potential and the intracellular Ca2+ concentration. Large conductance, 
Ca2+/voltage-sensitive K+ (BK) channels participate in this electromechanical coupling 
(Nelson et al., 1995; Brenner et al., 2000).  BK channels are activated by membrane 
depolarization and increases in intracellular Ca2+. 20-HETE has been shown to inhibit 
BK channels in canine basilar artery (Obara et al., 2002) and rat renal arterioles (Zou et 
al., 1996). BK channels can also be regulated by phosphorylation and are targets of PKC, 
which reduces open probability (Zhou et al., 2009). 
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We have shown previously that activation of A1AR couples with the Cyp4a 
metabolite, 20-HETE and mediates contraction of the aortic smooth muscle through a 
pathway involving PKCα and/or p-ERK1/2.  However, genetic ablation of the A1AR 
reduced the contractions in response to 20-HETE, in part, by reducing the expression of 
downstream signaling molecules (PKCα and p-ERK1/2) (Kunduri et al., 2013). To 
further understand the signaling transduction of A1AR and 20-HETE, we performed 
studies designed to test the hypothesis that activation of A1AR inhibits BK channels via a 
PKC-dependent mechanism.  
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Materials and Methods 
Animals 
A1KO mice (originally obtained from Dr. Jurgen Schnermann, NIDDK, NIH) were on 
C57BL/6 background. A1KO mice were backcrossed 4 generations with C57BL/6 (WT); 
genotypes were confirmed by polymerase chain reaction. C57BL/6 (WT) mice (originally 
purchased from The Jackson Laboratory, Bar Harbor, ME) were bred in-house. Equal 
number of males and females of 14-18 weeks of age were used in our studies, as no 
gender differences were observed. The Institutional Animal Care and Use Committee of 
West Virginia University provided regulatory oversight and protocols followed 
guidelines set forth in The Guide for the Care and Use of Laboratory Animals (National 
Research Council, 2011). Mice had free access to food and water and were housed on a 
12:12 hr light-dark cycle. Mice were killed with an overdose of sodium pentobarbital 
(150 mg/kg ip) and aortae were quickly harvested into ice-cold physiological saline 
solution. Adipose and connective tissue were removed under the magnification of a 
dissecting microscope. 
Isometric tension: Isometric tension experiments were conducted with small 
segments of WT and A1KO mice aortae as described previously in (Kunduri SS et al, 
2012). After equilibration, the responsiveness and stability of individual rings were 
checked by administration of PE (10-6 M) (Ansari et al., 2007b; Ponnoth et al., 2008; 
Ansari et al., 2009). The integrity of the vascular endothelium was assessed 
pharmacologically by acetylcholine (ACh, 10-6 M) (Ansari et al., 2007a; Ansari et al., 
2009) to produce relaxation of PE pre-contracted rings. The rings were washed several 
times with Krebs-Henseleit solution and allowed to equilibrate for 60 min before the 
experimental protocol began. The concentration-response curves (CRC) for 5'-N-
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ethylcarboxamido adenosine (NECA; 10-11-10-5M) and 2-chloro-N (6) 
cyclopentyladenosine (CCPA; 10-11-10-5M) were run in parallel in aortic rings from WT 
and A1KO mice. In all cases, drugs were administered to yield the next higher 
concentration only when the response to the earlier dose reached a steady state. A single 
concentration of 20-HETE (10-7M) was used for all the 20-HETE experiments (Ponnoth 
et al., 2012a). In all cases, 20-HETE was administered only when the PE response 
reached a steady state. In experiments where the effect of the antagonist was studied, the 
drug was added 30 min prior to the contraction of the tissue with PE and was present 
throughout the experiments. In all CRC figures, contraction (represented as positive (+) 
values) and relaxation (represented as negative (-) values) responses were expressed as a 
percentage of increase/decrease in the contraction with respect to PE (alone) in response 
to each concentration of agonist used. The concentration used for Penitrem A (Pen A) 
was 10-6M (Borbouse et al., 2009; Asano et al., 2012). For the rest of the drugs, CRCs 
were made (NS1619, KCl, PE, ACh, SNP and adenosine agonists) and the sub-maximal 
concentrations were chosen. 
Immunoblot analysis  
Aortae from WT and A1KO mice were homogenized with 150 µL radio-immuno 
precipitation assay buffer containing (mM) 20 Tris-HCl, 150 NaCl, 1 Na2EDTA, 1 
EGTA, 2.5 sodium pyrophosphate,1 beta-glycerophosphate, and 1 Na3VO4; plus 1% NP-
40, 1% sodium deoxycholate, and 1 µg/ml leupeptin. Samples were vortexed and then 
centrifuged for 10 min at 13,800 g at 4°C. Protein was measured using the Bradford dye 
procedure with bovine serum albumin as a standard (Bio-Rad Laboratories; Hercules, 
CA). The protein extract was divided into aliquots and stored at -80°C. Samples (25 µg of 
total protein) were loaded on slab gels (10% acrylamide; 1 mm thick), separated by SDS-
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PAGE, and transferred to nitrocellulose membranes (Hybond-ECL). Protein transfer was 
confirmed by visualization of prestained molecular weight markers (Bio-Rad). 
Membranes were blocked with 5% nonfat dry milk and incubated with primary antibody. 
A 1:5,000 primary antibody dilution used for BK α and β1 subunits (Alomone 
labortatories, Israel), while 1:10,000 dilutions were used for secondary antibody and β-
actin.  
Electrophysiology 
WT and A1KO mice aortae were digested in a physiological saline solution containing 
(mg/ml) 2 collagenase type-II, 1 soybean trypsin inhibitor, 1 bovine serum albumin, and 
1 elastase for 30 minutes at 37°C. Single cells were liberated by passing the tissue 
through the tip of a fire-polished Pasteur pipette. The suspension was passed through a 
100 µm nylon mesh and spun for 10 minutes at 10,000g. The pellet was resuspended in 
low Ca2+ physiological saline solution and cells were stored on ice for use within 8 hr. 
Cells were allowed to attach to glass coverslip, which was then transferred to the 
recording chamber.  Solutions flowed into the recording chamber by gravity at a rate of 
2-3 ml/min and the chamber had a volume of 0.2-0.3 ml. BK channel currents were 
recorded at room temperature from whole-cell patches as described previously (Asano et 
al., 2010). Bath solution contained (mM) 135 NaCl, 5 KCl, 2 CaCl2, 1 MgCl2, 10 glucose, 
10 HEPES free acid and 5 Tris base; pH 7.4. Pipette solution contained (mM) 140 KCl, 1 
MgCl2, 1 EGTA and 0.281 CaCl2 (pCa 7), 10 HEPES, 1 Mg-ATP, 0.1 Na-GTP, and 5 
Tris; pH 7.1. pClamp software and an Axopatch 200B amplifier were used (Molecular 
Devices; Sunnyvale, CA). Currents were low pass filtered at 1 kHz and digitized at 5 kHz. 
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Real Time PCR 
The aortic tissues from WT and A1KO were processed for total RNA isolation 
using the TRI reagent (MRC, Cincinnati, OH) followed by purification of the RNA in 
aqueous phase and removal of genomic DNA by an RNeasy Plus Micro Kit (QIAGEN, 
Hilden, Germany).This was followed by conversion of 0.5 g of total RNA into cDNA 
using High Capacity cDNA archive kit (Applied Biosystems, Foster City, CA) in a total 
volume of 20 µl. Real-time PCR was performed using an ABI PRISM 7300 Detection 
System (Applied Biosystems) using Taqman Universal Mastermix (Applied Biosystems, 
Branchburg, NJ) according to the instructions of the manufacturer. The reaction volume 
(20 µl) consisted of 10 µl of 2X Taqman Universal Mastermix, 4 µl of cDNA, and 1 µl of 
20X FAM-labeled Taqman gene expression assay. For the real-time PCR of the 
concerned genes (Cyp4a10, A1AR, A2AAR,A2BAR and A3AR ), the Taqman inventoried 
assays on-demand gene expression products  were purchased from Applied Biosystems 
(Foster City, CA). 18S rRNA (ribosomal RNA) was used as an endogenous control. The 
fold difference in expression of target cDNA was determined using the comparative cycle 
threshold (Ct) method as described earlier(Livak and Schmittgen, 2001). 
 
Statistics 
Data are expressed as mean ± SEM from n number of mice, because the treatment level 
(i.e., genotype) is on a per mouse basis. For patch clamp experiments, that means results 
from all cells from a single mouse aorta were averaged to represent n = 1. Current-
voltage relationships were analyzed by two-way repeated measures analysis of variance 
(ANOVA). This was followed with Bonferroni post hoc test to determine where 
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differences existed. When only two values were compared (e.g., BK subunit expression) 
an unpaired t-test was used. P < 0.05 was considered significant in all tests. 
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Results 
Total BK current and BK subunit expression in WT and A1KO mice aortic myocytes 
We performed whole-cell patch recordings on aortic smooth muscle cells from WT (Fig. 
3.1A) and A1KO (Fig. 3.1B) mice; we observed no difference in BK current. That is, 
whole-cell K+ current in smooth muscle cells was indistinguishable between WT and 
A1KO mice. Currents were normalized to cell capacitance (i.e., current density). The 
group data are shown in Fig.3.1C. BK α and β1 proteins were expressed in aortae from 
both WT and A1KO mice. BK α and β1 subunit proteins migrated at 100 and 25 kDa, 
respectively. There were no differences observed in the two protein levels between 
genotypes (Figs.3.1D and 3.1E). Thus, the molecular (protein) and functional (current) 
expression of BK channels was similar in smooth muscle cells from WT and A1KO mice. 
Effect of 20-HETE on BK current in WT and A1KO mice aortic myocytes 
To assess the reported inhibitory effect of 20-HETE on BK channels (Zou et al., 1996; 
Lange et al., 1997), whole-cell recordings were performed on WT and A1KO myocytes. 
We observed a decrease in the BK current in both WT (Fig.3.2A and 3.2B) and A1KO 
(Fig. 3.2D and 3.2E) smooth muscle cells. Mean current density at +100 mV in WT 
under control conditions was 76.4 ± 12.5 pA/pF (n=4); this was decreased to 51.6 ± 10.3 
pA/pF by 20-HETE (Fig. 3.2C). In smooth muscle cells from WT mice, 20-HETE 
decreased current density 33 ± 7%. Similarly in smooth muscle cells from A1KO mice, 
mean current density was 55.6 ± 10.3 pA/pF (n=4) and this was decreased to 41.4 ± 7 
pA/pF by 20-HETE (Fig. 3.2F). Thus, in myocytes from A1KO mice, 20-HETE 
decreased current density 24 ± 11%. 
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Effect of NECA on BK current in WT and A1KO mice aortic myocytes 
Whole-cell patch recordings were made in WT and A1KO aortic myocytes to determine 
the effect of NECA on BK current. NECA is a nonselective adenosine receptor agonist 
and can activate multiple AR subtypes simultaneously. Whole-cell recordings showed 
prominent BK current in smooth muscle cells from WT and A1KO mice. Caffeine (5 
mM) was used as a positive control to release Ca2+ and increase BK current in both WT 
and A1KO aortic smooth muscle cells (Figs. 3.3E and 3.3F). There was very little change 
in the BK current in the WT aortic myocytes when stimulated with 10 µM NECA (Fig. 
3.3E). In contrast, the BK current in A1KO aortic myocytes was significantly increased 
by 10 µM NECA (Fig.3.3F). The time-dependent increase in BK current with 10 µM 
NECA in A1KO smooth muscle cells was 52 ± 15% (n=7); this was significantly higher 
than the response to NECA in smooth muscle cells from WT mice (17 ± 3%; n=9; Fig. 
3.3G). The disparate responses to NECA in smooth muscle cells from WT and A1KO 
mice suggest that multiple AR subtypes are simultaneously regulating BK channels. Thus, 
the next experiment was to determine the effect of an A1AR-specific agonist on BK 
channels in smooth muscle cells from WT and A1KO mice. 
Effect of CCPA on BK current in WT and A1KO mice aortic myocytes 
CCPA (100 nM), an A1-selective agonist, decreased BK current in aortic smooth muscle 
cells from WT mice (Figs. 3.4A and 3.4B). The mean current density at +100 mV in WT 
was 52.1 ± 5.0 pA/pF (n=4) and decreased with the application of CCPA to 42.8 ± 6.2 
pA/pF (Fig. 3.4C). That is, CCPA decreased current density 19 ± 4% in smooth cells 
from WT mice. In contrast, CCPA had no effect on BK current in smooth muscle cells 
from A1KO mice (Figs. 3.4D and 3.4E). The mean current density at +100 mV in smooth 
muscle cells from A1KO mice was 55.2 ± 7.7 and 54.1 ± 3.9 pA/pF (n=4) in the absence 
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or presence of 100 nM CCPA, respectively (Fig. 3.4F). That is, current density in the 
presence of CCPA was 98 ± 7% of control in smooth muscle cells from A1KO mice. 
Effect of PKCα inhibition on BK current in WT and A1KO mice aortic myocytes 
As shown previously (Ponnoth et al., 2012a; Kunduri et al., 2013), PKCα is downstream 
of A1AR activation, 20-HETE production, and mediates contraction of smooth muscle. 
We determined if inhibition of PKCα affected regulation of BK current by A1AR 
activation in smooth muscle cells from WT and A1KO mice. When PKCα was inhibited 
with Gö6976 (100 nM) in WT smooth muscle cells, subsequent addition of CCPA (100 
nM) was no longer able to inhibit current (Figs. 3.5A and 3.5B; compare to Fig. 3.4A-C). 
In smooth muscle cells from WT mice, mean current density at +100 mV for Gö6976 was 
65.9 ± 18.6 pA/pF vs. 64.2 ± 16.6 pA/pF for CCPA + Gö6976 (Fig. 3.5C). That is, 
current density in the presence of CCPA was 99 ± 3% of control in smooth muscle cells 
from WT mice treated with Gö6976. There was no effect of CCPA on BK current in 
A1KO smooth muscle cells whether Gö6976 was present or not (Fig 4.5D-F; note that 
this is a result similar to that shown in Fig. 3.4D-F). The mean current density at +100 
mV in cells from A1KO mice for Gö6976 was 68.5 ± 13.6 pA/pF vs. 66.6 ± 13.2 pA/pF 
for CCPA + Gö6976 (Fig. 3.5F). That is, current density in the presence of CCPA was 97 
± 1% of control in Gö6976-treated smooth muscle cells from A1KO mice. 
Effect of NS1619 and Penitrem A on adenosine agonists’ induced response:  BK 
channel opener NS1619 had significantly increased relaxation in A1KO, but had no effect 
in the WT. We observed that the BK channel inhibitor Pen A had no effect on NECA 
induced responses in both the WT and A1KO (Fig. 3.5A). However, Pen A increased 
NECA induced contraction in WT (14.5±1.9%; 10-7M) as compared to the A1KO 
(3.7±4.5%; 10-7M). On using the A1 selective agonist, CCPA, we observed no difference 
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in contraction with the use of Pen A in WT, except at 10-5M, where higher relaxation was 
observed with Pen A treatment (-6.6 ± 2.8% vs.17 ± 1.2%; Fig. 3.5B).  
Effect of NS1619 and Penitrem A on 20-HETE induced contraction:  20-HETE 
induced contraction in both the WT and A1KO, however it was lower in A1KO. The BK 
channel opener, NS1619 (10µM) decreased the contraction in both the WT (17.3 ± 1.2% 
vs 33.4 ± 2.9%.)  and A1KO (5.7 ± 4.2%). NS1619 had further significantly decreased the 
contraction in the A1KO (5.7 ± 4.2%) as compared to WT (17.3 ± 1.2%). However, on 
using Pen A the contraction was restored to the control levels in both WT (26.1 ± 2.5%) 
and A1KO (16.3 ± 2.9%) (Fig. 3.6).  
mRNA expression of adenosine receptors in WT and A1KO mice:  As expected, A1 
receptor expression was observed in WT and not in A!KO. A2AAR, A2BAR and A3AR 
were expressed in both WT and A1KO. However, A2AAR was the highest in A1KO mice 
(Fig 3.7). 
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Figure 3.1: Whole-cell K+ current and BK channel subunit expression is similar in 
smooth muscle from WT and A1KO mice.  
Representative traces of whole-cell K+ current in aortic smooth muscle cells from WT 
(A) and A1KO mice (B). The voltage template used to elicit the currents in this and 
subsequent figures is shown below the trace in A; cells were held at -80 mV and stepped 
from -100 to +100 mV in 20 mV increments. (C) Group data representing whole-cell K+ 
current in aortic smooth muscle cells from WT (n = 13) and A1KO (n = 20) mice. (D) 
Representative Western blots from mouse aortae for BK channel subunit expression 
relative to β-actin (α = 100 kDa; β1 = 25 kDa; β-actin = 42 kDa). (E) Group data for BK 
α and β1 subunit expression in the aortae of WT (n = 6) and A1KO (n = 6) mice.  
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Figure3.2: Effect of 20-HETE on BK current in WT and A1KO aortic myocytes:  
Representative current traces are shown under control conditions (A) and with 0.1 µM 
20-HETE (B) in a smooth muscle cell from a WT mouse. The voltage template was the 
same as Fig. 4.1. (C) Group data (n = 5) show the decrease in the BK current by 20-
HETE in smooth muscle cells from WT mice. Representative traces are shown under 
control conditions (D) and with 0.1 µM 20-HETE (E) for a smooth muscle cell from an 
A1KO mouse. (F) Group data (n = 5) show the decrease in BK current by 0.1 µM 20-
HETE in smooth muscle cells from A1KO mice. *p<0.05 compared to the respective 
control. 
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Figure3.3: Effect of NECA on BK current in WT and A1KO aortic myocytes  
Representative currents under control conditions (A) and with 10 µM NECA (B) in WT. 
The voltage template was the same as Fig.4.1. Representative currents under control 
conditions (C) and with 10 µM NECA (D) in smooth muscle cells from A1KO mice. Data 
showing currents vs. time for 10 µM NECA and 5 mM caffeine in smooth muscle cells 
from WT (E) and in A1KO (F) mice (blank areas in the time course represent where the 
protocol was stopped to perform voltage steps) (G) Group data show that NECA 
increases the BK current more in smooth muscle cells from A1KO mice compared to WT 
mice. *p < 0.05 for WT vs. A1KO; n=7-9. 
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Figure 3.4: Effect of CCPA on BK current in WT and A1KO aortic myocytes  
Representative traces under control conditions (A) and with 0.1 µM CCPA (B) in a 
smooth muscle cell from a WT mouse. The voltage template was the same as Fig.4.1. (C) 
Group data representing the decrease in the BK current by CCPA in the WT mice (n = 4). 
Representative traces show current under control conditions (D) and with 0.1 µM CCPA 
(E) in a smooth muscle cell from an A1KO mouse. (F) Group data illustrate that there is 
no effect of CCPA on BK current in smooth muscle cells from A1KO mice. *p<0.05 
compared to untreated WT (n=4). 
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Figure 3.5: Effect of PKCα inhibitor, Gö6976 on BK current in WT and A1KO 
aortic myocytes 
Representative traces with 0.1 µM Gö6976 (A) and with 0.1 µM Gö6976 + 0.1 µM 
CCPA (B) in a smooth muscle cell from a WT mouse. The voltage template was the same 
as Fig.4.1.  (C) Group data demonstrate the effect of Gö6976 to prevent CCPA-induced 
inhibition of BK current in smooth muscle cells from WT mice (n =4). Representative 
traces with 0.1 µM Gö6976 (D) and with 0.1 µM Gö6976 + 0.1 µM CCPA (E) in a 
smooth muscle cell from an A1KO mouse. (F) Group data representing BK current in 
Gö6976-treated smooth muscle cells from A1KO mice (n = 4). 
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Figure 3.6 Effect of NS1619 on NECA induced relaxation.  
Data are expressed as mean ± SEM; **p<0.05 between WT+NS1619 and 
A1KO+NS1619 and *p<0.05 as compared to A1KO and A1KO +NS1619. 
  
87 
 
  
Figure 3.7 Effect of Penitrem A (Pen A) on adenosine agonists’ induced responses: 
(A)Effect of Penitrem A on NECA induced vascular response 
 Data are expressed as Mean ±SEM; *p<0.05 as between WT+Pen A and A1KO + Pen A; 
n=6-12; (B) Effect of CCPA on Penitrem A induced contraction: Data are expressed as 
Mean ± SEM; *p<0.05 as between WT+ Pen A and A1KO + Pen A; *p<0.05 as between 
WT and WT + Pen A; n=8-12 
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Figure 3.8 Effect of Penitrem A (BK channel inhbitor; Pen A) and NS1619 (BK 
channel opener;NS) on CCPA induced contraction.   
Values are mean ± SEM; n=6-12; *p<0.05 as compared to WT; #p<0.05 as compared to 
A1KO; $p<0.05 as compared to WT+NS; **p<0.05 as compared to WT + Pen A 
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Figure 3.9 Adenosine receptor expression in WT and A1KO mice aortae  
 Data are expressed as mean ± SEM (n=10). * p<0.05 compared to the WT 
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Figure 3.10: Adenosine A1 receptors regulate aortic smooth muscle contraction by 
inhibiting BK channels via PKC-α dependent mechanism.  
As shown previously in Fig 3.4, activation of A1AR by CCPA couples with PLCX via Gx.  
IP3, a metabolites of PLC action on phosphatidylinositol 4,5-bisphosphate, releases Ca2+ 
from the sarcoplasmic reticulum (SR) and activates BK channels. AA released by the 
DAG lipases is metabolized to 20-HETE by Cyp4a, which activates PKC-α. The latter 
apart from activating ERK1/2, inhibits the BK channels and results in the contraction of 
the aortic smooth muscle. Activation of BK channels results in hyperpolarization of the 
smooth muscle membrane which promotes a closure of L-type voltage dependent Ca2+ 
channels that are major players of smooth muscle contraction.   
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Discussion 
We tested the hypothesis that activation of A1AR inhibits BK channels in aortic smooth 
muscle via a PKC-dependent mechanism. This hypothesis was based on previous studies 
indicating: 1) that A1AR stimulation is associated with 20-HETE production and 
activation of PKC (Ponnoth et al., 2012a; Kunduri et al., 2013) and 2) 20-HETE and PKC 
can inhibit BK channels (Zou et al., 1996; Nowicki et al., 1997; Schubert et al., 1999; 
Zhou et al., 2009). We performed whole-cell patch clamp and Western blot studies using 
aortic smooth muscle cells and aortae of WT and A1KO mice. Our major findings 
included: 1) There were no differences in whole-cell K+ current in aortic smooth muscle 
cells from WT and A1KO mice, nor were there any differences in the expression of pore-
forming α or regulatory β1 subunit proteins. 2) Inhibition of BK current by 20-HETE was 
similar in aortic smooth muscle cells from WT and A1KO mice. 3) NECA, a non-
selective AR agonist increased BK current in aortic smooth muscle cells from both WT 
and A1KO mice, but the increase was greater in smooth muscle cells from mice lacking 
the A1AR. 4) CCPA, an A1AR-selective agonist, inhibited BK current in smooth muscle 
cells from WT, but not A1KO, mice. 5) Inhibition of PKCα with Gö6976 abolished the 
effect of CCPA to inhibit BK current in smooth muscle cells from WT mice. Together, 
these data lead us to conclude that, in aortic smooth muscle, A1AR stimulation inhibits 
BK channel activity and that this occurs via a mechanism involving PKCα. 
BK channels are ubiquitously expressed on the sarcolemma of vascular smooth 
muscles. BK channels are composed of pore-forming α subunits with or without 
regulatory β subunits. The β1 subunit, however, is commonly found in vascular smooth 
muscles  (Nelson and Quayle, 1995; Ledoux et al., 2006; Asano et al., 2010). The α 
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subunit is the voltage- and Ca2+-sensitive pore, while β subunits can modify many 
characteristics including pharmacology and Ca2+-sensitivity. We observed no difference 
in the expression of α or β1 BK subunits (Fig.3.1), suggesting that the channels are 
equally expressed in aortic smooth muscle cells from WT and A1KO mice. Further, there 
were no differences in BK current magnitude between WT and A1KO mice (Fig.3.1). We 
have previously shown that A1AR mediates contraction of smooth muscle via the 
arachidonic acid metabolite 20-HETE (Ponnoth et al., 2012a; Kunduri et al., 2013). 20-
HETE has been shown to inhibit BK channels in rat renal arteriolar smooth muscle cells 
(Zou et al., 1996; Sun et al., 1999). We have observed similar results in whole-cell patch 
recordings (Fig. 3.2). That is, 20-HETE decreased BK current similarly in smooth muscle 
cells from both WT and A1KO mice (Fig. 3.2). 20-HETE is a potent vasoconstrictor as 
shown previously by significant contractions in the aortae of both WT and A1KO mice 
(Ponnoth et al., 2012a; Kunduri et al., 2013). The BK channel opener NS1619 decreased 
this contraction with significantly higher reduction in the A1KO, implying the role of BK 
channels in the A1AR-20-HETE mediated signaling in the vascular response. On using 
Pen A in WT and A1KO, the contraction is restored to their respective control levels. This 
further underscores that A1AR via 20-HETE inhibits BK channel and attenuates 
relaxation of the smooth muscle cell 20-HETE activates PKC (Lange et al., 1997; 
Nowicki et al., 1997; Ponnoth et al., 2012a; Kunduri et al., 2013) and PKC may mediate 
contraction by inhibiting BK channel activity in rat cerebral arteries (Bonev and Nelson, 
1996), rabbit portal vein (Kitamura et al., 1992), canine basilar artery(Obara et al., 2002) 
and rat tail artery (Schubert et al., 1999). This inhibition depends on the sequential 
phosphorylation of two serines in the C-terminus of the BK α subunit (Zhou et al., 2009).  
In the present study, when PKCα was antagonized with Gö6976, CCPA could no longer 
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inhibit BK channel current (compare Figs. 3.4 and 3.5). This suggests that A1AR 
signaling through PKCα is negatively coupled to BK channels, perhaps by 20-HETE. 
The non-selective adenosine agonist NECA relaxes smooth muscle by acting on 
A2AR (Rump et al., 1999; Tawfik et al., 2005; Ponnoth et al., 2009), whereas the A1AR-
selective agonist CCPA contracts smooth muscle (Ponnoth et al., 2012a; Kunduri et al., 
2013). Activation of BK channels by A2AR could lead to membrane potential 
hyperpolarization and contribute to the relaxation of smooth muscle, whereas inhibition 
of BK channels by A1AR could cause depolarization and contribute to contraction. We 
observed that NECA increased BK current significantly in A1KO as compared to the WT 
(Fig. 3.3). This suggests that the increase in the BK current could be due to the absence of 
A1 and the non-selective action of NECA on other adenosine receptors (e.g. A2AR) in the 
A1KO. We have shown that the A2A receptor expression is upregulated in A1KO mice and 
this might also be a factor in the larger responses to NECA. There is evidence showing 
that A2AAR, through EETs, activate BK channels (Carroll et al., 2006; Ray and Marshall, 
2006). Furthermore, by using the A1 selective agonist CCPA we demonstrated a decrease 
in BK current in smooth muscle cells from WT mice, but no effect in smooth muscle 
cells from the A1KO mice. This is the first evidence in the literature showing that A1AR 
activation inhibits BK current. As the A1AR is known to mediate contraction (Tawfik et 
al., 2005; Wang et al., 2010; Kunduri et al., 2013), we suggest this may be mediated by 
inhibition of BK channels. It should be noted, however, that there are reports of A1 
activating KATP channels (Dart and Standen, 1993) and linking to nitric oxide-dependent 
smooth muscle relaxation (Ray and Marshall, 2006). The reasons for such differences are 
not readily apparent, but may perhaps be attributed to the vascular beds and species. 
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However, it was surprising to observe in vascular reactivity experiments that the 
use of BK channel inhibitor, Pen A did not alter the contraction in NECA induced or 
CCPA induced concentration responses (Fig.3.7A and Fig.3.7B). Previous studies using 
adenosine or A2A receptor agonist in other vessels have produced differing results 
depending on the tissue and species used. In renal arteries, combination of calcium 
dependent potassium channel inhibitors, apamin and charybdotoxin didnot have any 
effect on the A2A agonist dilation, but Ibtx at 0.1µmol/L had very little effect (Rump et al., 
1999). Similar results were obtain ned by Carroll MA et al (Carroll et al., 2006) in renal 
preglomerular vessels. In their study, adenosine mediated dilation via A2A through EETs 
of renal preglomerular vessels was inhibited by 100nM Ibtx. However, there has been no 
study showing the interaction of adenosine-mediated response via A1 and BK channels. 
Though A1 is primarily know to mediate contraction, there is evidence showing that A1 
mediates vasodilation through KATP channel in the rat aortic endothelium (Ray and 
Marshall, 2006), in rat diaphragmatic arterioles(Danialou et al., 1997), in the rat skeletal 
muscle (Bryan and Marshall, 1999). Thus, it is quite possible in the present study that the 
adenosine in the whole tissue consisting of endothelium and the smooth muscle might 
cause contraction through the A1 receptors via inhibition of KATP channels or other K+ 
channels. This suggests that there could be another pathway in the whole tissue via which 
A1AR mediates contraction. 
Adenosine, via multiple receptor subtypes, contracts and relaxes vascular smooth 
muscle through several mechanisms, including the regulation of K+ channels (Dart and 
Standen, 1993). While adenosine-mediated increases in KATP channel activity are 
generally well accepted (Sharifi Sanjani et al., 2013), reports regarding the role of BK 
channels in adenosine-induced smooth muscle relaxation vary widely. In canine coronary 
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arterioles, vasodilation in response to adenosine is inhibited by iberiotoxin (a very 
selective BK channel antagonist) (Cabell et al., 1994). Blocking BK channels inhibits 
vasodilation to 2-chloroadenosine in pig coronary arterioles (Borbouse et al., 2009); 
however, the role of BK channels in this response is abolished in pigs with metabolic 
syndrome (Borbouse et al., 2009). Thus, it could be pathology that explains why BK 
channels play no role in adenosine-induced vasodilation human coronary arterioles (Sato 
et al., 2005), as they are typically collected from patients with heart disease. Conversely, 
it may be that BK channels play little, if any role, in adenosine-induced vasodilation, as 
this has been reported in the majority of studies from pig coronary arterioles (Hein and 
Kuo, 1999; Hein et al., 2001; Heaps and Bowles, 2002). However, it cannot be ignored 
that BK channels are reported to contribute to adenosine-induced relaxation or 
vasodilation of rat cerebral arterioles (Paterno et al., 1996), rabbit renal arteries (Rump et 
al., 1999), rat aortas (Ray and Marshall, 2006), and rat preglomerular microvessels 
(Carroll et al., 2006). Further, adenosine increases a Ca2+-dependent K+ current in smooth 
muscle cells from the rat mesenteric artery that may be mediated by BK channels (Li and 
Cheung, 2000). At present, there is little consensus regarding the role of BK channels in 
adenosine-induced smooth muscle relaxation and very little data directly addressing 
whether adenosine increases BK current in smooth muscle cells isolated from those same 
arteries or arterioles. Thus, from our data, we conclude that A1AR signaling inhibits BK 
channels via 20-HETE and PKCα. However, in the whole tissue consisting of the 
endothelium and smooth muscle, there could be other potassium channels or ion channels 
playing role in mediating contraction through A1AR and this needs to be further explored 
to have a complete understanding of the signaling mechanism involved in A1AR 
mediated contraction. 
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4. CHAPTER FOUR: CONCLUSIONS 
 
The work presented in this dissertation establishes a relationship between A1AR 
and Cyp4a.We have shown that A1AR mediated contraction of the smooth muscle 
involves Cyp4a product, 20-HETE via PKC-α and ERK 1/2 dependent pathway. 
Furthermore, this effect on the smooth muscle occurs by the inhibition of BK channel in a 
PKC-α dependent manner. 
  The first evidence for an interaction between A1AR and Cyp4a is the effect of the 
Cyp4a inhibitor (HET0016) on adenosine agonists’ (NECA and CCPA) elicited vascular 
responses in WT and A1KO mice aortae. Due to the similar responses to adenosine 
agonists in the mice mesenteric arteries and aortae, we used aortae for these studies(Teng 
et al., 2011). Pharmacological inhibition of Cyp4a dramatically reduced the contraction 
responses induced by NECA, in both the WT and the A1KO mice aortae and a 
significantly higher relaxation was observed in NECA-induced aortic responses in A1KO 
(Fig. 2.2A).  
These findings were further confirmed when Cyp4a inhibitor (HET0016) 
attenuated the vasoconstriction evoked by the A1 agonist, CCPA in the WT with no 
significant difference in the treated and untreated A1KO tissues (Fig.2.2B). This coupled 
with lower Cyp4a protein levels in A1KO mice aortae (Fig. 2.1A) as compared to WT 
suggest a role for Cyp4a in adenosine-elicited contraction of the smooth muscle through 
the A1AR.  
20-HETE is known to be a potent vasoconstrictor in several vascular beds. When 
administered exogenously in our experiments, it elicited contraction responses in both 
WT and A1KO at very low concentrations of 10-11M (Fig 2.3A-D). Our data show that 
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20-HETE vascular responses in aortae and mesenteric arteries are lower in A1KO 
compared to the WT (Fig.2.3E). Moreover, the Cyp4a functional activity evaluated by the 
20-HETE formation rates in the aortic microsomes was found to be lower in the A1KO as 
compared to the WT mice (Fig 2.4). This further underscores the role of Cyp4a in A1AR 
mediated vasoconstriction. 
There is a dynamic interplay between the metabolites of the two pathways of 
Cyp450 enzymes, EETs and 20-HETEs, in the modulation of vascular homeostasis. As 
Cyp4a and Cyp2c products have functionally antagonistic effects, we investigated if 
Cyp2c29 has any relationship to the A1AR mediated vascular responses. We observed 
that Cyp2c29 protein levels were significantly up- regulated in A1KO mice as compared 
to the WT (Fig 2.5A). Since we have seen an up-regulation of Cyp2c29 in A1KO 
compared to WT mice, it is quite possible that relaxation observed in A1KO mice by 
Cyp4a inhibition is due to Cyp2c29 product EETs and due to the inhibition of Cyp4a that 
limits the production of 20-HETE. This observation was confirmed by the enhanced 
CCPA mediated vasoconstriction in the presence of the Cyp-epoxygenase inhibitor, 
MSPPOH (Fig.2.5B). We have shown earlier that Cyp4a protein levels are up regulated 
with MSPPOH treatment (Nayeem et al., 2008). In the WT, although Cyp-epoxygenases 
were inhibited, a higher contraction observed with MSPPOH treatment is due to higher 
levels of Cyp4a and in the A1KO, the higher vascular response is due to inhibition of the 
Cyp-epoxygenases. Thus, the down-regulation of Cyp4a and an up-regulation of Cyp2c29 
protein levels promote the relaxation observed in the A1KO littermates. This inverse 
relationship between Cyp4a and Cyp2c is consistent with findings from other 
investigators in rat afferent arterioles and preglomerular arterioles (Hercule and Oyekan, 
2000; Imig et al., 2000). 
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The next aim was to determine the signaling mechanism by which adenosine A1 
receptor-20-HETE pathway mediates contraction of the smooth muscle downstream. 
Exogenous administration of 20-HETE produced similar higher contraction response in 
WT than the A1KO, both in the mice aortae and mesenteric arteries (Fig.2.3), thus, 
suggesting that the signaling proteins downstream of 20-HETE are essential in Cyp4a 
modulation of A1AR mediated vasoconstriction. The use of a specific PKC-α blocker 
attenuated the 20-HETE mediated vasoconstrictor response in WT and A1KO mice aortae 
(Fig.2.6A-C). Similarly, pharmacological inhibition of ERK1/2 with PD98059 decreased 
the 20-HETE-elicited contraction in the WT and almost abolished the contractile tone in 
the A1KO (Fig2.7A-C). However, the greater blockade of the vasoconstrictor responses 
with ERK inhibitor than with the PKC-α inhibitor implies that MAPK pathway activation 
may involve several kinases like PKA, PKC, rho kinases or Ras activation or a cross talk 
between the different tyrosine kinase receptors. These data substantiate the role of PKC-α 
and ERK1/2 in A1AR mediated vasoconstriction through 20-HETE (Fig. 2.6 and 2.7). 
 Electrophysiological studies have revealed that BK channels negatively 
regulate the A1AR–20-HETE mediated aortic smooth muscle contraction.  Our data 
showed that the total BK current and BK protein expression was unchanged in both WT 
and A1KO aortic smooth muscle cells (Fig.3.1). 20-HETE decreased the BK current in 
our studies as reported by several groups in different vascular beds and species (Fig.3.2). 
20-HETE is a potent vasoconstrictor as shown by the significant contraction in WT and 
A1KO (Ponnoth et al., 2012a; Kunduri et al., 2013). The BK channel opener NS1619 
decreased this contraction with significantly higher reduction in the A1KO, implying the 
role of BK channels in the A1AR-20-HETE mediated signaling in the vascular response. 
On using Pen A in WT and A1KO, the contraction is restored to their respective control 
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levels. This further underscores that A1AR via 20-HETE inhibits BK channel and 
attenuates relaxation of the smooth muscle cell (Fig 3.8) 
  Adenosine receptor stimulation with NECA increased the BK current in A1KO 
and not in WT (Fig.3.3).  This suggests that A1AR negatively regulates the BK channel 
and the lack of it removes the inhibition. As cited previously, A2AR is known to couple 
with EETs and BK channels in mediating relaxation. We have shown in this dissertation 
that A2AR is up-regulated in A1KO mice aortae (Fig.3.9). It is quite plausible that the 
increase in BK current could also be contributed byA2AR receptors via EETs. Use of the 
A1 selective agonist CCPA decreased the BK current in WT with no effect on the A1KO 
aortic smooth muscle cells (Fig.3.4).   
However, it was surprising to observe in vascular reactivity experiments that the 
use of BK channel inhibitor, Pen A did not alter the contraction in NECA induced or 
CCPA induced concentration responses (Fig.3.7). Previous studies using adenosine or 
A2A receptor agonist in other vessels have produced differing results depending on the 
tissue and species used. In renal arteries, combination of calcium dependent potassium 
channel inhibitors, apamin and charybdotoxin didnot have any effect on the A2A agonist 
dilation, but Ibtx at 0.1µmol/L had very little effect (Rump et al., 1999). Similar results 
were obtain ned by Carroll MA et al (Carroll et al., 2006) in renal preglomerular vessels. 
In their study, adenosine mediated dilation via A2A through EETs of renal preglomerular 
vessels was inhibited by 100nM Ibtx. However, there has been no study showing the 
interaction of adenosine-mediated response via A1 and BK channels. Though A1 is 
primarily know to mediate contraction, there is evidence showing that A1 mediates 
vasodilation through KATP channel in the rat aortic endothelium (Ray and Marshall, 2006), 
in rat diaphragmatic arterioles(Danialou et al., 1997), in the rat skeletal muscle (Bryan 
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and Marshall, 1999). Thus, it is quite possible in the present study that the adenosine in 
the whole tissue consisting of endothelium and the smooth muscle might cause 
contraction through the A1 receptors via inhibition of KATP channels or other K+ channels. 
This suggests that there could be another pathway in the whole tissue via which A1AR 
mediates contraction. 
Thus, in summary we conclude that adenosine A1 receptor by coupling with 20-
HETE and PKC-α limits adenosine-mediated relaxation in the aortic smooth muscle cells 
by inhibiting BK channels. However, in the whole tissue consisting of the endothelium 
and smooth muscle, there could be other potassium channels or ion channels playing role 
in mediating contraction through A1AR and this needs to be further explored to have a 
complete understanding of the signaling mechanism involved in A1AR mediated 
contraction. 
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Figure 4.1: Schematic showing the events leading from activation of A1AR coupled 
to Cyp4a product, 20-HETE and mediating contraction through PKC-α and p-
ERK1/2 and BK channels 
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Figure 4.2: Schematic showing the events in the absence of A1AR. NECA possibly 
activates A2AR, leading to activation of Cyp-epoxygenases , which produce EETs 
and actiavte KATP channels 
 (Nayeem et al., 2008; Ponnoth et al., 2012a; Ponnoth et al., 2012b); EETs diffuse out of 
the endothelial cell and are also known to activate BK channels in the smooth muscle. 
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Figure 4.3: Effect of Glibenclamide(Glib; 10µM) on CCPA induced contraction.  
Data are expressed Mean ± SEM; *p<0.05 between WT and WT+Glib and **p<0.05 
between A1KO and A1KO+Glib; n=6  
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Future Directions 
The next step for this project would be to determine the ion channels in the 
endothelium that could be involved in the regulation of the vascular tone by A1AR and 
Cyp450 metabolites. Our preliminary vascular reactivity experiments showed that KATP 
inhibitor, Glibenclamide (Glib) significantly increased the CCPA induced contraction in 
WT as well as A1KO (Fig.4.3). This suggests that Glib- sensitive KATP channels 
contribute to adenosine-mediated relaxation and inhibition of these channels contribute to 
the A1mediated contraction.  
KATP channels are octameric complexes composed of four SUR and four Kir 
subunits. They are found in the vascular smooth muscle of both resistance and conduit 
arteries (Quayle et al., 1997). Several studies have shown that A1AR mimics adenosine 
effects by coupling with KATP in the rat aortic endothelium and causing release of nitric 
oxide (NO) (Ray and Marshall, 2006) in pig coronary arterioles smooth muscle cells 
(Dart and Standen, 1993), rat diaphragmatic arterioles (Danialou et al., 1997) and in the 
rat skeletal muscle (Bryan and Marshall, 1999). Our lab has shown previously that A1AR 
is up-regulated in A2AKO mice aortae (Ponnoth et al., 2012b) and Glib causes higher 
contraction to NECA in A2AKO (Ponnoth et al., 2012b). This meshes well with our 
preliminary data suggesting that inhibition of the KATP channel is involved in the A1AR 
regulation of vascular tone. Furthermore, our lab has shown that the endothelial KATP 
channels are activated by the A2AAR-Cyp-epoxygenases pathway in the mouse aorta 
(Ponnoth et al., 2012a). Given this evidence, we speculate that in the endothelium, the 
activation of A1AR causes inhibition of KATP channels and this signal is transduced to 
smooth muscle resulting in its contraction.  
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However, more experiments such as vascular reactivity studies to confirm the 
involvement of endothelial KATP channels in A1AR mediated responses are needed. 
Electrophysiological experiments can be done to further confirm the findings using the 
A1KO and WT aortic endothelial cells. However, the signaling and the role of Cyp450 
metabolites pathway in mediating this vascular function is unknown and needs to be 
studied. Since both the Cyp450 metabolites and adenosine play a role in the preservation 
of a normal endothelial functioning, understanding the relationship between them will 
provide a deeper insight of the factors underlying endothelial dysfunction, a major 
contributor to several cardiovascular diseases. 
The role of Cyp4a metabolite, 20-HETE in blood pressure regulation is well 
documented, and 20-HETE functions as a pro-hypertensive or as an antihypertensive 
eicosanoid depending on its expression site. In the renal tubules, it functions as an anti-
hypertensive by inhibiting the Na+ transport and increasing Na+ loss. In contrast, in the 
peripheral vessels it functions as a pro-hypertensive, by increasing the vascular tone, 
thereby increasing the peripheral vascular resistance and the arterial pressure (Williams et 
al., 2010) . There is overwhelming evidence that mutations in Cyp4a11 and Cyp4f2 lead 
to the development of hypertension in human population studies. Moreover, prolonged 
hypertension is a harbinger for atrial fibrillation, left ventricular hypertrophy, myocardial 
infarction, congestive heart failure leading to end stage renal disease and stroke (Kraja et 
al.; Dobbelsteyn et al., 2001).  
There are conflicting reports of involvement of A1AR in blood pressure regulation. 
Brown et al, 2001 and Wang et al, 2010 (Brown et al., 2001; Wang et al., 2010) have 
shown that blood pressure levels are elevated in A1KO mice, whereas, Sun et al, 2001 
and Schweda et al, 2005 (Sun et al., 2001; Schweda et al., 2005) have shown no 
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difference in blood pressure between the WT and A1KO mice. Although the role of 
A1AR in regulation of heart rate and cardio-protective action after an ischemic insult is 
well-documented (Jacobson and Gao, 2006), its role in blood pressure regulation remains 
ambiguous. 
Thus, the findings of this dissertation, which shed some light on the relationship 
between A1AR and 20-HETE, can serve as the basis for further exploration of the role of 
A1AR in blood pressure.   
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6. APPENDIX A 
 
This section provides preliminary data to determine the effect of adenosine agonists in 
WT and A1KO mice aortae 
Fig. A.1.Preliminary experiments were carried out to determine the effect of NECA in 
WT (C-57/BL6) and A1KO mice. NECA induced relaxation in both WT and A1KO. 
However, NECA induced relaxation was significantly higher in A1KO mice due to 
ablation of A1AR gene (n=8-12). Data are expressed as Mean± SEM, *p<0.05 as 
compared to WT; (n=8-12). 
 
 
NECA CONCENTRATION RESPONSE CURVE IN WT AND A1KO MICE 
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Fig.A.2.Preliminary experiments were carried out to determine the effect of CCPA in WT 
(C-57/BL6) and A1KO mice. CCPA induced contraction in WT and the lack of A1AR 
gene results in relaxation in A1KO. Data are expressed as Mean± SEM, *p<0.05 as 
compared to WT; (n=8-12). 
  
 
CCPA INDUCED CONCENTRATION RESPONSE CURVE 
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Fig.A.3.Ach induced relaxation in WT and A1KO mice aortae and mesenteric arteries. 
There was no difference in the acetylcholine induced responses in WT and A1KO mice in 
both aortae and mesenteric arteries. Data are expressed as Mean± SEM, *p<0.05 as 
compared to WT; (n=6-12). 
 
 
 ACETYLCHOLINE INDUCED RELAXATION 
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APPENDIX B 
 
This section provides preliminary data to determine the involvement of L-type 
Ca2+channels in the A1AR and 20-HETE mediated contraction using WT and A1KO mice 
aortae. Also, the effect of Iberiotoxin on CCPA induced contraction. The results observed 
were similar to the effect of Penitrem A. 
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Fig.B.1.To determine the involvement of L-VDCC in A1AR mediated contraction, we 
assessed the effect of Nifedipine on CCPA induced contraction. Nifedipine (Nif) 
inhibited CCPA-induced contraction and resulted in relaxation similar to control A1KO. 
Nif did not effect CCPA induced contraction in A1KO mice aortae. Data are expressed as 
Mean± SEM, *p<0.05 as compared to WT; (n=8-12) 
 
EFFECT OF NIFEDIPINE (Nif) ON CCPA- INDUCED CONTRACTION 
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Fig.B.2.To determine the involvement of L-VDCC in 20-HETE mediated contraction, we 
assessed the effect of Nifedipine on 20-HETE induced contraction. Nifedipine (Nif) 
attenuated 20-HETE-induced contraction in both WT and A1KO. However, the decrease 
in contraction was higher in A1KO by Nif. *p<0.05 as compared to WT and #p<0.05 as 
compared to A1KO. 
 
 
EFFECT OF NIFEDIPINE ON 20-HETE INDUCED CONTRACTION 
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Fig.B.3.Iberiotoxin (Ibtx; BK channel inhibitor) had no effect on CCPA induced 
contraction in WT. Data are expressed as Mean ± SEM; n=6 
 
EFFECT OF IBERIOTOXIN ON CCPA INDUCED CONTRACTION 
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APPENDIX C 
 
This section provides preliminary data to determine the effect of adenosine agonists in 
WT and Cyp2c29KO mice aortae. It also shows ACh response of WT and Cyp2c29KO 
mice aortae and mesenteric arteries. These mice were obtained from NIEHS to further 
explore the role of adenosine receptors and CYP metabolites. However, the results 
weren’t promising. 
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 Fig.C.1.NECA induced concentration response in WT and Cyp2c29KO. Data are 
expressed as Mean ± SEM, n=6  
 
NECA CONCENTRACTION RESPONSE IN Cyp2c29KO MICE 
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Fig.C.2.CCPA induced concentration response in WT and Cyp2c29KO. Data are 
expressed as Mean ± SEM, n=6.  
 
 
CCPA CONCENTRATION RESPONSE CURVE IN Cyp2c29KO MICE 
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Fig.C.3.CGS induced concentration response in WT and Cyp2c29KO. Data are expressed 
as Mean ± SEM, n=6.  
 
 
CGS CONCENTRATION CURVE IN Cyp2c29KO MICE 
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Fig.C.4.ACh induced relaxation was no different in WT and Cyp2c29Ko mice. Data are 
expressed as mean ± SEM; n=8-10 
 
 
ACETYLCHOLINE INDUCED RELAXATION IN Cyp2c29KO MICE 
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